返回首页 在线留言 联系我们
首页 > 产品展示 > > 所有 > Cayman ChemicalCayman CAC-10674-10URB93710 mg

产品中心

Cayman CAC-10674-10URB93710 mg

  • 型   号:Cayman Chemical
  • 价   格:

Cayman公司成立于1980年,在过去20多年的发展过程中,始终保持着为全球科研工作者提供高质、优价研究产品的宗旨。该公司目前可以提供 2,138 多种生化和免疫试剂,涉及肿瘤、氧化氮、神经学、凋亡、氧化性损伤、内分泌学等研究领域。
Cayman CAC-10674-10URB93710 mg

分享到:

Cayman公司成立于1980年,在过去20多年的发展过程中,始终保持着为全球科研工作者提供高质、优价研究产品的宗旨。该公司目前可以提供 2,138 多种生化和免疫试剂,涉及肿瘤、氧化氮、神经学、凋亡、氧化性损伤、内分泌学等研究领域。非常有特色的检测试剂盒包括类花生酸类物质、游离的生物标志、环核苷、激素及氧化氮等。此外,还提供多种高质量试剂,如类花生酸类物质、氧化氮试剂及许多相关脂质、脂肪酸、酶和抗体等。Cayman非常愿意接受各地客户的要求,合成复杂和不稳定分子。
 Cayman CAC-10674-10 URB937 10 mg

Cayman CAC-10674-10 URB937 10 mg

 

Cayman CAC-10011249-50 CAY10576 50 mg 19404

Cayman CAC-10011250-1 NH125 1 mg 415.8

Cayman CAC-10011250-10 NH125 10 mg 3326.4

Cayman CAC-10011250-5 NH125 5 mg 1878.8

Cayman CAC-10011250-50 NH125 50 mg 14553

Cayman CAC-10011251-1 TWS119 1 mg 446.6

Cayman CAC-10011251-10 TWS119 10 mg 1786.4

Cayman CAC-10011251-25 TWS119 25 mg 3911.6

Cayman CAC-10011251-5 TWS119 5 mg 1124.2

Cayman CAC-10011255-1 NSC 210902 1 mg 200.2

Cayman CAC-10011255-10 NSC 210902 10 mg 1601.6

Cayman CAC-10011255-5 NSC 210902 5 mg 908.6

Cayman CAC-10011255-50 NSC 210902 50 mg 7007

Cayman CAC-10011256-1 CAY10577 1 mg 200.2

Cayman CAC-10011256-10 CAY10577 10 mg 1601.6

Cayman CAC-10011256-5 CAY10577 5 mg 908.6

Cayman CAC-10011256-50 CAY10577 50 mg 7007

Cayman CAC-10011263-100 15-Lipoxygenase-2 (human recombinant) 100 µg 6683

Cayman CAC-10011264-1 CAY10578 1 mg 200.2

Cayman CAC-10011264-10 CAY10578 10 mg 1601.6

Cayman CAC-10011264-25 CAY10578 25 mg 3511.2

Cayman CAC-10011264-5 CAY10578 5 mg 908.6

Cayman CAC-10011269-1 Fulvestrant 1 mg 231

Cayman CAC-10011269-10 Fulvestrant 10 mg 1848

Cayman CAC-10011269-5 Fulvestrant 5 mg 1047.2

Cayman CAC-10011269-50 Fulvestrant 50 mg 8085

Cayman CAC-10011286-1 Chenodeoxycholic Acid 1 g 154

Cayman CAC-10011286-10 Chenodeoxycholic Acid 10 g 1232

Cayman CAC-10011286-25 Chenodeoxycholic Acid 25 g 2695

Cayman CAC-10011286-5 Chenodeoxycholic Acid 5 g 693

Cayman CAC-10011288-1 Half Volume 96-Well Solid Plate (white) 1 ea 184.8

Cayman CAC-10011288-5 Half Volume 96-Well Solid Plate (white) 5 ea 693

Cayman CAC-10011297-1 96-Well Solid Plate (black) with lid 1 ea 323.4

Cayman CAC-10011297-5 96-Well Solid Plate (black) with lid 5 ea 1216.6

Cayman CAC-10011298-1 Stearic Acid 1 g 184.8

Cayman CAC-10011298-10 Stearic Acid 10 g 739.2

Cayman CAC-10011298-500 Stearic Acid 500 mg 123.2

Cayman CAC-10011298-5 Stearic Acid 5 g 492.8

Cayman CAC-10011300-1 NBD-Stearoyl-2-Arachidonoyl-sn-glycerol 1 mg 2695

Cayman CAC-10011300-10 NBD-Stearoyl-2-Arachidonoyl-sn-glycerol 10 mg 19835.2

Cayman CAC-10011300-5 NBD-Stearoyl-2-Arachidonoyl-sn-glycerol 5 mg 11334.4

Cayman CAC-10011300-500 NBD-Stearoyl-2-Arachidonoyl-sn-glycerol 500 µg 1416.8

Cayman CAC-10011301-1 p38 MAPK Monoclonal Antibody (Clone 9F12) 1 ea 3988.6

Cayman CAC-10011305-100 17(S)-HETE 100 µg 6652.8

Cayman CAC-10011305-25 17(S)-HETE 25 µg 1848

Cayman CAC-10011305-50 17(S)-HETE 50 µg 3511.2

Cayman CAC-10011321-100 8-iso Prostaglandin E2-d4 100 µg 7376.6

Cayman CAC-10011321-25 8-iso Prostaglandin E2-d4 25 µg 2048.2

Cayman CAC-10011321-50 8-iso Prostaglandin E2-d4 50 µg 3896.2

Cayman CAC-10011322-100 Cysteinyl Leukotriene Express ELISA Monoclonal Antibody 100 dtn 924

Cayman CAC-10011322-500 Cysteinyl Leukotriene Express ELISA Monoclonal Antibody 500 dtn 3465

Cayman CAC-10011323-100 Cysteinyl Leukotriene Express AChE Tracer 100 dtn 2849

Cayman CAC-10011323-500 Cysteinyl Leukotriene Express AChE Tracer 500 dtn 10687.6

Cayman CAC-10011325-10 Immunoassay Buffer A Concentrate (10X) 10 ml 246.4

Cayman CAC-10011332-1 Plerixafor (hydrochloride hydrate) 1 mg 200.2

Cayman CAC-10011332-10 Plerixafor (hydrochloride hydrate) 10 mg 1601.6

Cayman CAC-10011332-5 Plerixafor (hydrochloride hydrate) 5 mg 908.6

Cayman CAC-10011332-50 Plerixafor (hydrochloride hydrate) 50 mg 7007

Cayman CAC-10011336-1 Avenanthramide-C methyl ester 1 mg 1262.8

Cayman CAC-10011336-10 Avenanthramide-C methyl ester 10 mg 9270.8

Cayman CAC-10011336-5 Avenanthramide-C methyl ester 5 mg 5297.6

Cayman CAC-10011336-500 Avenanthramide-C methyl ester 500 µg 662.2

Cayman CAC-10011337-10 Diphenylphosphine Acid 10 mg 616

Cayman CAC-10011337-100 Diphenylphosphine Acid 100 mg 4527.6

Cayman CAC-10011337-5 Diphenylphosphine Acid 5 mg 323.4

Cayman CAC-10011337-50 Diphenylphosphine Acid 50 mg 2587.2

Cayman CAC-10011344-10 Steviol 10 mg 2156

Cayman CAC-10011344-25 Steviol 25 mg 5205.2

Cayman CAC-10011344-5 Steviol 5 mg 1155

Cayman CAC-10011344-50 Steviol 50 mg 9825.2

Cayman CAC-10011347-1 Glycerophospho-N-Arachidonoyl Ethanolamine 1 mg 1031.8

Cayman CAC-10011347-10 Glycerophospho-N-Arachidonoyl Ethanolamine 10 mg 8254.4

Cayman CAC-10011347-5 Glycerophospho-N-Arachidonoyl Ethanolamine 5 mg 4650.8

Cayman CAC-10011348-1 Taprostene (free acid) 1 mg 2171.4

Cayman CAC-10011348-5 Taprostene (free acid) 5 mg 9116.8

Cayman CAC-10011348-500 Taprostene (free acid) 500 µg 1139.6

Cayman CAC-10011349-1 Dimebolin (hydrochloride) 1 mg 277.2

Cayman CAC-10011349-10 Dimebolin (hydrochloride) 10 mg 1940.4

Cayman CAC-10011349-25 Dimebolin (hydrochloride) 25 mg 4851

Cayman CAC-10011349-5 Dimebolin (hydrochloride) 5 mg 1247.4

Cayman CAC-10011355-12 HRP Stop Solution 12 ml 662.2

Cayman CAC-10011355-30 HRP Stop Solution 30 ml 1401.4

Cayman CAC-10011355-60 HRP Stop Solution 60 ml 2479.4

Cayman CAC-10011356-1 Glycerophospho-N-Palmitoyl Ethanolamine 1 mg 1031.8

Cayman CAC-10011356-10 Glycerophospho-N-Palmitoyl Ethanolamine 10 mg 8254.4

Cayman CAC-10011356-5 Glycerophospho-N-Palmitoyl Ethanolamine 5 mg 4650.8

Cayman CAC-10011357-1 Glycerophospho-N-Oleoyl Ethanolamine 1 mg 1031.8

Cayman CAC-10011357-10 Glycerophospho-N-Oleoyl Ethanolamine 10 mg 8254.4

Cayman CAC-10011357-5 Glycerophospho-N-Oleoyl Ethanolamine 5 mg 4650.8

Cayman CAC-10011360-100 14,15-Leukotriene C4 100 µg 6251.8

Cayman CAC-10011360-25 14,15-Leukotriene C4 25 µg 2170.8

Cayman CAC-10011360-50 14,15-Leukotriene C4 50 µg 3587.6

Cayman CAC-10011361-100 14,15-Leukotriene D4 100 µg 6251.8

Cayman CAC-10011361-25 14,15-Leukotriene D4 25 µg 2170.8

Cayman CAC-10011361-50 14,15-Leukotriene D4 50 µg 3587.6

Cayman CAC-10011362-100 14,15-Leukotriene E4 100 µg 6529

Cayman CAC-10011362-25 14,15-Leukotriene E4 25 µg 2247.8

Cayman CAC-10011362-50 14,15-Leukotriene E4 50 µg 3726.2

Cayman CAC-10011385-100 Bim/BOD (IN) Polyclonal Antibody 100 µg 5108.4

Cayman CAC-10011385-25 Bim/BOD (IN) Polyclonal Antibody 25 µg 2237.4

Cayman CAC-10011387-100 Cu/Zn SOD (rat) Polyclonal Antibody 100 µl 6098.4

Cayman CAC-10011387-25 Cu/Zn SOD (rat) Polyclonal Antibody 25 µl 3009.6

Cayman CAC-10011388-100 Cu/Zn SOD (human) Polyclonal Antibody 100 µl 6098.4

Cayman CAC-10011388-25 Cu/Zn SOD (human) Polyclonal Antibody 25 µl 3009.6

Cayman CAC-10011389-100 Mn SOD (rat) Polyclonal Antibody 100 µl 6098.4

Cayman CAC-10011389-25 Mn SOD (rat) Polyclonal Antibody 25 µl 3009.6

Cayman CAC-10011390-100 Mn SOD (human) Polyclonal Antibody 100 µl 6098.4

Cayman CAC-10011390-25 Mn SOD (human) Polyclonal Antibody 25 µl 3009.6

Cayman CAC-10011424-200 GRP94 Monoclonal Antibody (Clone 9G10) 200 µg 5207.4

Cayman CAC-10011424-50 GRP94 Monoclonal Antibody (Clone 9G10) 50 µg 2415.6

Cayman CAC-10011432-100 CD74 Monoclonal Antibody (Clone PIN1) 100 µg 4672.8

Cayman CAC-10011432-25 CD74 Monoclonal Antibody (Clone PIN1) 25 µg 2217.6

Cayman CAC-10011433-100 Hsf1 Monoclonal Antibody (Clone 10H8) 100 µg 4474.8

Cayman CAC-10011433-25 Hsf1 Monoclonal Antibody (Clone 10H8) 25 µg 2019.6

Cayman CAC-10011434-100 Hsf2 Monoclonal Antibody (Clone 3E2) 100 µg 4474.8

Cayman CAC-10011434-25 Hsf2 Monoclonal Antibody (Clone 3E2) 25 µg 2019.6

Cayman CAC-10011435-100 PSD95 Monoclonal Antibody (Clone 6G6) 100 µg 5405.4

Cayman CAC-10011435-25 PSD95 Monoclonal Antibody (Clone 6G6) 25 µg 2554.2

Cayman CAC-10011436-100 PSD95 Monoclonal Antibody (Clone 7E3) 100 µg 5405.4

Cayman CAC-10011436-25 PSD95 Monoclonal Antibody (Clone 7E3) 25 µg 2554.2

Cayman CAC-10011437-100 CaMKII Monoclonal Antibody (Clone 6G9) 100 µg 5207.4

Cayman CAC-10011437-25 CaMKII Monoclonal Antibody (Clone 6G9) 25 µg 2336.4

Cayman CAC-10011438-100 CaMKII (Phospho-Thr286/Thr287) Monoclonal Antibody (Clone 22B1) 100 µg 5405.4

Cayman CAC-10011438-25 CaMKII (Phospho-Thr286/Thr287) Monoclonal Antibody (Clone 22B1) 25 µg 2633.4

Cayman CAC-10011442-100 FKBP52 Monoclonal Antibody (Clone Hi52C) 100 µg 6098.4

Cayman CAC-10011442-25 FKBP52 Monoclonal Antibody (Clone Hi52C) 25 µg 2831.4

Cayman CAC-10011443-100 LAMP1 Monoclonal Antibody (Clone Ly1C6) 100 µg 5643

Cayman CAC-10011443-25 LAMP1 Monoclonal Antibody (Clone Ly1C6) 25 µg 3168

Cayman CAC-10011444-100 LAMP2 Monoclonal Antibody (Clone GL2A7) 100 µg 5425.2

Cayman CAC-10011444-25 LAMP2 Monoclonal Antibody (Clone GL2A7) 25 µg 3029.4

Cayman CAC-10011450-1 MRS2179 1 mg 462

Cayman CAC-10011450-10 MRS2179 10 mg 2772

Cayman CAC-10011450-5 MRS2179 5 mg 1509.2

Cayman CAC-10011453-100 Lipoxin A5 100 µg 13289.6

Cayman CAC-10011453-25 Lipoxin A5 25 µg 4126.6

Cayman CAC-10011453-50 Lipoxin A5 50 µg 7299

Cayman CAC-10011454-1 Adenosine Receptor A2A Monoclonal Antibody (Clone 7FG-G5-A2) 1 ea 3988.6

Cayman CAC-10011490-100 Okadaic Acid 100 µg 1493.8

Cayman CAC-10011490-25 Okadaic Acid 25 µg 415.8

Cayman CAC-10011490-50 Okadaic Acid 50 µg 785.4

Cayman CAC-10011497-100 Dinophysistoxin-1 100 µg 5775

Cayman CAC-10011498-100 Brevetoxin B 100 µg 3064.6

Cayman CAC-10011499-1 phytanoyl-Coenzyme A (triethylammonium salt) 1 mg 1016.4

Cayman CAC-10011499-10 phytanoyl-Coenzyme A (triethylammonium salt) 10 mg 8131.2

Cayman CAC-10011499-25 phytanoyl-Coenzyme A (triethylammonium salt) 25 mg 17787

Cayman CAC-10011499-5 phytanoyl-Coenzyme A (triethylammonium salt) 5 mg 4573.8

Cayman CAC-10011545-100 ent-8-iso Prostaglandin F2α 100 µg 5436.2

Cayman CAC-10011545-25 ent-8-iso Prostaglandin F2α 25 µg 1509.2

Cayman CAC-10011545-50 ent-8-iso Prostaglandin F2α 50 µg 2864.4

Cayman CAC-10011546-1 AL 34662 1 mg 138.6

Cayman CAC-10011546-10 AL 34662 10 mg 1108.8

Cayman CAC-10011546-5 AL 34662 5 mg 631.4

Cayman CAC-10011546-50 AL 34662 50 mg 4851

Cayman CAC-10011561-1 SC-51089 1 mg 231

Cayman CAC-10011561-10 SC-51089 10 mg 1986.6

Cayman CAC-10011561-25 SC-51089 25 mg 4050.2

Cayman CAC-10011561-5 SC-51089 5 mg 1047.2

Cayman CAC-10011562-1 L-655,240 1 mg 739.2

Cayman CAC-10011562-10 L-655,240 10 mg 5913.6

Cayman CAC-10011562-25 L-655,240 25 mg 12936

Cayman CAC-10011562-5 L-655,240 5 mg 3326.4

Cayman CAC-10011563-96 HDAC Fluorometric Activity Assay Kit 96 wells 4912

Cayman CAC-10011564-96 HDAC1 Inhibitor Screening Assay Kit 96 wells 5220

Cayman CAC-10011565-1 L-161,982 1 mg 415.8

Cayman CAC-10011565-10 L-161,982 10 mg 3326.4

Cayman CAC-10011565-5 L-161,982 5 mg 1878.8

Cayman CAC-10011565-50 L-161,982 50 mg 14553

Cayman CAC-10011566-96 SIRT3 Direct Fluorescent Screening Assay Kit 96 wells 5220

Cayman CAC-10011617-1 HDAC1 Positive Control 1 ea 1108.2

Cayman CAC-10011618-1 HDAC1 (human recombinant) Assay Reagent 1 ea 1616.4

Cayman CAC-10011619-1 Terbinafine (hydrochloride) 1 g 7268.8

Cayman CAC-10011619-100 Terbinafine (hydrochloride) 100 mg 908.6

Cayman CAC-10011619-250 Terbinafine (hydrochloride) 250 mg 2156

Cayman CAC-10011619-500 Terbinafine (hydrochloride) 500 mg 4096.4

Cayman CAC-10011620-100 Raloxifene (hydrochloride) 100 mg 739.2

Cayman CAC-10011620-250 Raloxifene (hydrochloride) 250 mg 1740.2

Cayman CAC-10011620-50 Raloxifene (hydrochloride) 50 mg 385

Cayman CAC-10011620-500 Raloxifene (hydrochloride) 500 mg 3080

Cayman CAC-10011659-1 Trolox 1 g 847

Cayman CAC-10011659-250 Trolox 250 mg 385

Cayman CAC-10011659-500 Trolox 500 mg 585.2

Cayman CAC-10011669-50 Soluble Epoxide Hydrolase (human recombinant) 50 µg 5066

Cayman CAC-10011670-50 Soluble Epoxide Hydrolase (mouse recombinant) 50 µg 5066

Cayman CAC-10011671-96 Soluble Epoxide Hydrolase Inhibitor Screening Assay Kit 96 wells 3818.6

Cayman CAC-10011718-1 1-Deoxynojirimycin (hydrochloride) 1 mg 354.2

Cayman CAC-10011718-10 1-Deoxynojirimycin (hydrochloride) 10 mg 2833.6

Cayman CAC-10011718-5 1-Deoxynojirimycin (hydrochloride) 5 mg 1601.6

Cayman CAC-10011718-50 1-Deoxynojirimycin (hydrochloride) 50 mg 12397

Cayman CAC-10011720-10 ent-8-iso-15(S)-Prostaglandin F2α-d9 10 µg 1986.6

Cayman CAC-10011720-100 ent-8-iso-15(S)-Prostaglandin F2α-d9 100 µg 15892.8

Cayman CAC-10011720-25 ent-8-iso-15(S)-Prostaglandin F2α-d9 25 µg 4712.4

Cayman CAC-10011720-50 ent-8-iso-15(S)-Prostaglandin F2α-d9 50 µg 8947.4

Cayman CAC-10011721-10 ent-8-iso Prostaglandin F2α-d9 10 µg 1986.6

Cayman CAC-10011721-100 ent-8-iso Prostaglandin F2α-d9 100 µg 15892.8

Cayman CAC-10011721-25 ent-8-iso Prostaglandin F2α-d9 25 µg 4712.4

Cayman CAC-10011721-50 ent-8-iso Prostaglandin F2α-d9 50 µg 8947.4

Cayman CAC-10011724-10 Propenyl-L-NIO (hydrochloride) 10 mg 1493.8

Cayman CAC-10011724-25 Propenyl-L-NIO (hydrochloride) 25 mg 3542

Cayman CAC-10011724-5 Propenyl-L-NIO (hydrochloride) 5 mg 785.4

Cayman CAC-10011724-50 Propenyl-L-NIO (hydrochloride) 50 mg 6283.2

Cayman CAC-10011725-1 Glycerol Cell-Based Assay Kit 1 ea 3465

Cayman CAC-10011914-1 Deoxynojirimycin Tetrabenzyl Ether 1 mg 385

Cayman CAC-10011914-10 Deoxynojirimycin Tetrabenzyl Ether 10 mg 3080

Cayman CAC-10011914-5 Deoxynojirimycin Tetrabenzyl Ether 5 mg 1740.2

Cayman CAC-10011914-50 Deoxynojirimycin Tetrabenzyl Ether 50 mg 13475

Cayman CAC-10011925-1 JNJ-7777120 1 mg 231

Cayman CAC-10011925-10 JNJ-7777120 10 mg 1848

Cayman CAC-10011925-5 JNJ-7777120 5 mg 1047.2

Cayman CAC-10011925-50 JNJ-7777120 50 mg 8085

Cayman CAC-10012088-10 Ethyl-L-NIO (hydrochloride) 10 mg 1262.8

Cayman CAC-10012088-100 Ethyl-L-NIO (hydrochloride) 100 mg 9270.8

Cayman CAC-10012088-5 Ethyl-L-NIO (hydrochloride) 5 mg 662.2

Cayman CAC-10012088-50 Ethyl-L-NIO (hydrochloride) 50 mg 5297.6

Cayman CAC-10012201-500 Sphingosine Kinase 1 Polyclonal FITC Antibody 500 µl 4450.6

Cayman CAC-10012298-1 Ebselen Oxide 1 mg 569.8

Cayman CAC-10012298-10 Ebselen Oxide 10 mg 4558.4

Cayman CAC-10012298-25 Ebselen Oxide 25 mg 9979.2

Cayman CAC-10012298-5 Ebselen Oxide 5 mg 2571.8

Cayman CAC-10012422-1 Rabbit Anti-LDL Receptor Primary Antibody 1 ea 1570.8

Cayman CAC-10012424-10 CAY10583 10 mg 1401.4

Cayman CAC-10012424-25 CAY10583 25 mg 3326.4

Cayman CAC-10012424-5 CAY10583 5 mg 739.2

Cayman CAC-10012424-50 CAY10583 50 mg 5913.6

Cayman CAC-10012431-1 PD 184161 1 mg 323.4

Cayman CAC-10012431-10 PD 184161 10 mg 2587.2

Cayman CAC-10012431-25 PD 184161 25 mg 5667.2

Cayman CAC-10012431-5 PD 184161 5 mg 1463

Cayman CAC-10012445-96 His-Tag Detection ELISA Kit 96 solid wells 3049.2

Cayman CAC-10012445-96s His-Tag Detection ELISA Kit 96 strip wells 3049.2

Cayman CAC-10012447-1 CG 4305 1 mg 10102.4

Cayman CAC-10012447-100 CG 4305 100 µg 1262.8

Cayman CAC-10012447-500 CG 4305 500 µg 5682.6

Cayman CAC-10012536-1 CAY10592 1 mg 431.2

Cayman CAC-10012536-10 CAY10592 10 mg 3449.6

Cayman CAC-10012536-5 CAY10592 5 mg 1940.4

Cayman CAC-10012539-1 CAY10597 1 mg 877.8

Cayman CAC-10012539-10 CAY10597 10 mg 7022.4

Cayman CAC-10012539-5 CAY10597 5 mg 3957.8

Cayman CAC-10012540-1 SIRT3 Direct Assay Buffer (10X) 1 ea 769.4

Cayman CAC-10012541-1 SIRT3 (human recombinant) Direct Assay Reagent 1 ea 1785.8

Cayman CAC-10012542-1 SIRT3 Direct Peptide 1 ea 2016.8

Cayman CAC-10012543-1 SIRT3 Direct NAD+ 1 ea 769.4

Cayman CAC-10012544-1 SIRT3 Direct Nicotinamide 1 ea 769.4

Cayman CAC-10012545-1 SIRT3 Direct Developer 1 ea 1231.4

Cayman CAC-10012546-1 SIRT3 Direct Fluorophore 1 ea 769.4

Cayman CAC-10012553-1 CAY10595 1 mg 816.2

Cayman CAC-10012553-10 CAY10595 10 mg 6529.6

Cayman CAC-10012553-5 CAY10595 5 mg 3680.6

Cayman CAC-10012554-10 Resolvin D1 10 µg 2525

Cayman CAC-10012554-100 Resolvin D1 100 µg 15815.2

Cayman CAC-10012554-25 Resolvin D1 25 µg 5173.8

Cayman CAC-10012554-50 Resolvin D1 50 µg 9270.2

Cayman CAC-10012555-1 Sodium Hydrogen Sulfide (hydrate) 1 g 277.2

Cayman CAC-10012555-10 Sodium Hydrogen Sulfide (hydrate) 10 g 2217.6

Cayman CAC-10012555-25 Sodium Hydrogen Sulfide (hydrate) 25 g 4851

Cayman CAC-10012555-5 Sodium Hydrogen Sulfide (hydrate) 5 g 1247.4

Cayman CAC-10012556-1 Phytomonic Acid 1 mg 831.6

Cayman CAC-10012556-10 Phytomonic Acid 10 mg 6652.8

Cayman CAC-10012556-5 Phytomonic Acid 5 mg 3742.2

Cayman CAC-10012559-1 TP Receptor (human) Polyclonal FITC Antibody 1 ea 4450.6

Cayman CAC-10012562-1 CAY10566 1 mg 831.6

Cayman CAC-10012562-10 CAY10566 10 mg 6652.8

Cayman CAC-10012562-25 CAY10566 25 mg 14553

Cayman CAC-10012562-5 CAY10566 5 mg 3742.2

Cayman CAC-10012565-10 CAY10568 10 mg 446.6

Cayman CAC-10012565-100 CAY10568 100 mg 3572.8

Cayman CAC-10012565-25 CAY10568 25 mg 1062.6

Cayman CAC-10012565-50 CAY10568 50 mg 2017.4

Cayman CAC-10012567-1 7(Z),11(Z)-Heptacosadiene 1 mg 646.8

Cayman CAC-10012567-10 7(Z),11(Z)-Heptacosadiene 10 mg 5174.4

Cayman CAC-10012567-5 7(Z),11(Z)-Heptacosadiene 5 mg 2910.6

Cayman CAC-10012567-50 7(Z),11(Z)-Heptacosadiene 50 mg 22638

Cayman CAC-10012577-100 Diallyl Trisulfide 100 mg 1724.8

Cayman CAC-10012577-25 Diallyl Trisulfide 25 mg 477.4

Cayman CAC-10012577-250 Diallyl Trisulfide 250 mg 3819.2

Cayman CAC-10012577-50 Diallyl Trisulfide 50 mg 908.6

Cayman CAC-10012582-1 Diallyl Disulfide 1 g 1108.8

Cayman CAC-10012582-100 Diallyl Disulfide 100 mg 277.2

Cayman CAC-10012582-500 Diallyl Disulfide 500 mg 693

Cayman CAC-10012583-1 cis-ACCP 1 mg 338.8

Cayman CAC-10012583-10 cis-ACCP 10 mg 2710.4

Cayman CAC-10012583-5 cis-ACCP 5 mg 1524.6

Cayman CAC-10012583-50 cis-ACCP 50 mg 11858

Cayman CAC-10012588-10 A-803467 10 mg 847

Cayman CAC-10012588-100 A-803467 100 mg 6252.4

Cayman CAC-10012588-5 A-803467 5 mg 446.6

Cayman CAC-10012588-50 A-803467 50 mg 3572.8

Cayman CAC-10012591-1 CCT018159 1 mg 200.2

Cayman CAC-10012591-10 CCT018159 10 mg 1601.6

Cayman CAC-10012591-5 CCT018159 5 mg 908.6

Cayman CAC-10012591-50 CCT018159 50 mg 7007

Cayman CAC-10012592-10 Lacosamide 10 mg 1078

Cayman CAC-10012592-25 Lacosamide 25 mg 1909.6

Cayman CAC-10012592-5 Lacosamide 5 mg 600.6

Cayman CAC-10012592-50 Lacosamide 50 mg 3511.2

Cayman CAC-10012597-100 Allopurinol 100 g 1386

Cayman CAC-10012597-25 Allopurinol 25 g 385

Cayman CAC-10012597-50 Allopurinol 50 g 739.2

Cayman CAC-10012600-10 Myricetin 10 mg 323.4

Cayman CAC-10012600-100 Myricetin 100 mg 1940.4

Cayman CAC-10012600-25 Myricetin 25 mg 723.8

Cayman CAC-10012600-50 Myricetin 50 mg 1293.6

Cayman CAC-10012601-100 DNA/RNA Oxidative Damage AChE Tracer 100 dtn 3126.2

Cayman CAC-10012601-500 DNA/RNA Oxidative Damage AChE Tracer 500 dtn 11719.4

Cayman CAC-10012603-1 DNA/RNA Oxidative Damage ELISA Standard 1 ea 785.4

Cayman CAC-10012605-1 Hispidin 1 mg 1001

Cayman CAC-10012605-5 Hispidin 5 mg 4004

Cayman CAC-10012609-10 Eeyarestatin 1 10 mg 1293.6

Cayman CAC-10012609-25 Eeyarestatin 1 25 mg 2541

Cayman CAC-10012609-5 Eeyarestatin 1 5 mg 677.6

Cayman CAC-10012628-1 (S)-MG132 1 mg 184.8

Cayman CAC-10012628-10 (S)-MG132 10 mg 1478.4

Cayman CAC-10012628-5 (S)-MG132 5 mg 831.6

Cayman CAC-10012628-50 (S)-MG132 50 mg 6083

Cayman CAC-10012642-1 Nefazodone (hydrochloride) 1 g 1724.8

Cayman CAC-10012642-250 Nefazodone (hydrochloride) 250 mg 539

Cayman CAC-10012642-500 Nefazodone (hydrochloride) 500 mg 1031.8

Cayman CAC-10012643-1 Steatosis Colorimetric Assay Kit 1 ea 2849

Cayman CAC-10012659-1 Ki16425 1 mg 446.6

Cayman CAC-10012659-10 Ki16425 10 mg 1786.4

Cayman CAC-10012659-100 Ki16425 100 mg 11165

Cayman CAC-10012659-5 Ki16425 5 mg 1232

Cayman CAC-10012670-1 Chloroquine Positive Control (25 mM) 1 ea 400.4

Cayman CAC-10012671-1 Steatosis Assay Hematoxylin 1 ea 323.4

Cayman CAC-10012672-10 N-cis-tetradec-9Z-enoyl-L-Homoserine lactone 10 mg 1078

Cayman CAC-10012672-25 N-cis-tetradec-9Z-enoyl-L-Homoserine lactone 25 mg 2571.8

Cayman CAC-10012672-5 N-cis-tetradec-9Z-enoyl-L-Homoserine lactone 5 mg 569.8

Cayman CAC-10012672-50 N-cis-tetradec-9Z-enoyl-L-Homoserine lactone 50 mg 4558.4

Cayman CAC-10012673-10 N-cis-hexadec-9Z-enoyl-L-Homoserine lactone 10 mg 1047.2

Cayman CAC-10012673-25 N-cis-hexadec-9Z-enoyl-L-Homoserine lactone 25 mg 2494.8

Cayman CAC-10012673-5 N-cis-hexadec-9Z-enoyl-L-Homoserine lactone 5 mg 554.4

Cayman CAC-10012673-50 N-cis-hexadec-9Z-enoyl-L-Homoserine lactone 50 mg 4435.2

Cayman CAC-10012674-10 N-cis-octadec-9Z-enoyl-L-Homoserine lactone 10 mg 1047.2

Cayman CAC-10012674-25 N-cis-octadec-9Z-enoyl-L-Homoserine lactone 25 mg 2494.8

Cayman CAC-10012674-5 N-cis-octadec-9Z-enoyl-L-Homoserine lactone 5 mg 554.4

Cayman CAC-10012674-50 N-cis-octadec-9Z-enoyl-L-Homoserine lactone 50 mg 4435.2

Cayman CAC-10012681-1 FR900098 (sodium salt) 1 mg 693

Cayman CAC-10012681-10 FR900098 (sodium salt) 10 mg 2248.4

Cayman CAC-10012681-5 FR900098 (sodium salt) 5 mg 1247.4

Cayman CAC-10012682-1 CAY10585 1 mg 169.4

Cayman CAC-10012682-10 CAY10585 10 mg 1355.2

Cayman CAC-10012682-25 CAY10585 25 mg 2972.2

Cayman CAC-10012682-5 CAY10585 5 mg 770

Cayman CAC-10012694-1 Benzisoxazole Hsp90 Inhibitor 1 mg 1509.2

Cayman CAC-10012694-10 Benzisoxazole Hsp90 Inhibitor 10 mg 12073.6

Cayman CAC-10012694-5 Benzisoxazole Hsp90 Inhibitor 5 mg 6791.4

Cayman CAC-10012698-10 NVP-AUY922 10 mg 3080

Cayman CAC-10012698-5 NVP-AUY922 5 mg 1925

Cayman CAC-10012699-1 JMV3002 1 mg 5790.4

Cayman CAC-10012699-100 JMV3002 100 µg 723.8

Cayman CAC-10012699-5 JMV3002 5 mg 24255

Cayman CAC-10012699-500 JMV3002 500 µg 3264.8

Cayman CAC-10012708-1 A-922500 1 mg 462

Cayman CAC-10012708-10 A-922500 10 mg 3696

Cayman CAC-10012708-25 A-922500 25 mg 8085

Cayman CAC-10012708-5 A-922500 5 mg 2079

Cayman CAC-10013-1 Prostaglandin A1-biotin 1 mg 3203.2

Cayman CAC-10013-100 Prostaglandin A1-biotin 100 µg 400.4

Cayman CAC-10013-5 Prostaglandin A1-biotin 5 mg 14014

Cayman CAC-10013-500 Prostaglandin A1-biotin 500 µg 1801.8

Cayman CAC-10014-1 Ac-YVAD-CMK 1 mg 877.8

Cayman CAC-10014-10 Ac-YVAD-CMK 10 mg 6468

Cayman CAC-10014-5 Ac-YVAD-CMK 5 mg 3696

Cayman CAC-10014-500 Ac-YVAD-CMK 500 µg 462

Cayman CAC-10016-1 Ac-YVAD-CHO 1 mg 693

Cayman CAC-10016-10 Ac-YVAD-CHO 10 mg 5205.2

Cayman CAC-10016-5 Ac-YVAD-CHO 5 mg 2772

Cayman CAC-10017-1 Ac-DEVD-CHO 1 mg 1078

Cayman CAC-10017-10 Ac-DEVD-CHO 10 mg 7977.2

Cayman CAC-10017-5 Ac-DEVD-CHO 5 mg 4558.4

Cayman CAC-10017-500 Ac-DEVD-CHO 500 µg 569.8

Cayman CAC-10018-1 DDMS 1 mg 862.4

Cayman CAC-10018-10 DDMS 10 mg 6899.2

Cayman CAC-10018-5 DDMS 5 mg 3880.8

Cayman CAC-10020-1 Prostaglandin A1 ethyl ester 1 mg 831.6

Cayman CAC-10020-10 Prostaglandin A1 ethyl ester 10 mg 6652.8

Cayman CAC-10020-5 Prostaglandin A1 ethyl ester 5 mg 3742.2

Cayman CAC-10022-1 F16 1 mg 138.6

Cayman CAC-10022-10 F16 10 mg 1108.8

Cayman CAC-10022-5 F16 5 mg 631.4

Cayman CAC-10022-50 F16 50 mg 4851

Cayman CAC-10023-1 (S)-AL 8810 1 mg 723.8

Cayman CAC-10023-10 (S)-AL 8810 10 mg 5790.4

Cayman CAC-10023-5 (S)-AL 8810 5 mg 3264.8

Cayman CAC-10024-1 Acetaminophen 1 kg 1324.4

Cayman CAC-10024-100 Acetaminophen 100 g 292.6

Cayman CAC-10024-250 Acetaminophen 250 g 477.4

Cayman CAC-10024-500 Acetaminophen 500 g 800.8

Cayman CAC-10026-1 T0070907 1 mg 138.6

Cayman CAC-10026-10 T0070907 10 mg 1108.8

Cayman CAC-10026-5 T0070907 5 mg 631.4

Cayman CAC-10026-50 T0070907 50 mg 4851

Cayman CAC-10028-1 Pioglitazone (potassium salt) 1 mg 338.8

Cayman CAC-10028-10 Pioglitazone (potassium salt) 10 mg 1247.4

Cayman CAC-10028-5 Pioglitazone (potassium salt) 5 mg 693

Cayman CAC-10028-50 Pioglitazone (potassium salt) 50 mg 4912.6

Cayman CAC-10029-1 MK-571 1 mg 385

Cayman CAC-10029-10 MK-571 10 mg 1509.2

Cayman CAC-10029-5 MK-571 5 mg 862.4

Cayman CAC-10029-50 MK-571 50 mg 6745.2

Cayman CAC-10031-1 POV-PC 1 mg 1108.8

Cayman CAC-10031-10 POV-PC 10 mg 8870.4

Cayman CAC-10031-25 POV-PC 25 mg 19404

Cayman CAC-10031-5 POV-PC 5 mg 4989.6

Cayman CAC-10032-10 N-(α-Linolenoyl) Tyrosine 10 mg 1663.2

Cayman CAC-10032-100 N-(α-Linolenoyl) Tyrosine 100 mg 12289.2

Cayman CAC-10032-5 N-(α-Linolenoyl) Tyrosine 5 mg 877.8

Cayman CAC-10032-50 N-(α-Linolenoyl) Tyrosine 50 mg 7022.4

Cayman CAC-10033-100 Lipoxin A4 methyl ester 100 µg 13012.4

Cayman CAC-10033-25 Lipoxin A4 methyl ester 25 µg 4049.6

Cayman CAC-10033-50 Lipoxin A4 methyl ester 50 µg 7160.4

Cayman CAC-10035-1 8-iso Prostaglandin A1 1 mg 2125.2

Cayman CAC-10035-100 8-iso Prostaglandin A1 100 µg 385

Cayman CAC-10035-500 8-iso Prostaglandin A1 500 µg 1247.4

Cayman CAC-10037-1 10-Nitrolinoleate 1 mg 4681.6

Cayman CAC-10037-100 10-Nitrolinoleate 100 µg 585.2

Cayman CAC-10037-500 10-Nitrolinoleate 500 µg 2633.4

Cayman CAC-10038-1 TMS 1 mg 169.4

Cayman CAC-10038-10 TMS 10 mg 1355.2

Cayman CAC-10038-5 TMS 5 mg 770

Cayman CAC-10038-50 TMS 50 mg 5929

Cayman CAC-10039-1 FR122047 (hydrate) 1 mg 215.6

Cayman CAC-10039-10 FR122047 (hydrate) 10 mg 1724.8

Cayman CAC-10039-5 FR122047 (hydrate) 5 mg 970.2

Cayman CAC-10039-50 FR122047 (hydrate) 50 mg 7546

Cayman CAC-10043-1 15(R)-Iloprost 1 mg 2571.8

Cayman CAC-10043-10 15(R)-Iloprost 10 mg 18972.8

Cayman CAC-10043-5 15(R)-Iloprost 5 mg 10841.6

Cayman CAC-10043-500 15(R)-Iloprost 500 µg 1355.2

Cayman CAC-10044-1 PGPC 1 mg 523.6

Cayman CAC-10044-10 PGPC 10 mg 3880.8

Cayman CAC-10044-5 PGPC 5 mg 2217.6

Cayman CAC-10044-500 PGPC 500 µg 277.2

Cayman CAC-10045-10 UCM707 10 mg 1909.6

Cayman CAC-10045-25 UCM707 25 mg 4512.2

Cayman CAC-10045-5 UCM707 5 mg 1001

Cayman CAC-10045-50 UCM707 50 mg 8008

Cayman CAC-10046-10 URB597 10 mg 939.4

Cayman CAC-10046-100 URB597 100 mg 6899.2

Cayman CAC-10046-5 URB597 5 mg 492.8

Cayman CAC-10046-50 URB597 50 mg 3942.4

Cayman CAC-10047-1 8-iso Misoprostol 1 mg 1001

Cayman CAC-10047-10 8-iso Misoprostol 10 mg 8008

Cayman CAC-10047-5 8-iso Misoprostol 5 mg 4512.2

Cayman CAC-10049-100 6(S)-Lipoxin A4 100 µg 13012.4

Cayman CAC-10049-25 6(S)-Lipoxin A4 25 µg 4049.6

Cayman CAC-10049-50 6(S)-Lipoxin A4 50 µg 7160.4

Cayman CAC-10054-1 GW 3965 (hydrochloride) 1 mg 539

Cayman CAC-10054-10 GW 3965 (hydrochloride) 10 mg 2156

Cayman CAC-10054-5 GW 3965 (hydrochloride) 5 mg 1463

Cayman CAC-10057-10 BAY 41-2272 10 mg 2494.8

Cayman CAC-10057-25 BAY 41-2272 25 mg 5236

Cayman CAC-10057-5 BAY 41-2272 5 mg 1309

Cayman CAC-10057-50 BAY 41-2272 50 mg 9825.2

Cayman CAC-10065-1 15-deoxy-Δ12,14-Prostaglandin A1 1 mg 2401.8

Cayman CAC-10065-5 15-deoxy-Δ12,14-Prostaglandin A1 5 mg 9008.4

Cayman CAC-10065-500 15-deoxy-Δ12,14-Prostaglandin A1 500 µg 1801.2

Cayman CAC-10070-1 15-epi Prostaglandin A1 1 mg 1925

Cayman CAC-10070-100 15-epi Prostaglandin A1 100 µg 385

Cayman CAC-10070-500 15-epi Prostaglandin A1 500 µg 1355.2

Cayman CAC-10072-100 Ursolic Acid 100 mg 585.2

Cayman CAC-10072-250 Ursolic Acid 250 mg 1463

Cayman CAC-10072-50 Ursolic Acid 50 mg 354.2

Cayman CAC-10073-1 (+)-Abscisic Acid 1 mg 246.4

Cayman CAC-10073-10 (+)-Abscisic Acid 10 mg 1971.2

Cayman CAC-10073-5 (+)-Abscisic Acid 5 mg 1108.8

Cayman CAC-10073-50 (+)-Abscisic Acid 50 mg 8624

Cayman CAC-10075-1 CAY10452 1 mg 385

Cayman CAC-10075-10 CAY10452 10 mg 2125.2

Cayman CAC-10075-25 CAY10452 25 mg 4527.6

Cayman CAC-10075-5 CAY10452 5 mg 1247.4

Cayman CAC-10080-1 16,16-dimethyl Prostaglandin A1 1 mg 1078

Cayman CAC-10080-10 16,16-dimethyl Prostaglandin A1 10 mg 8624

Cayman CAC-10080-5 16,16-dimethyl Prostaglandin A1 5 mg 4851

Cayman CAC-100830-1 Caveolin 1/3 Polyclonal Antiserum 1 ea 3988.6

Cayman CAC-10091-10 Etoricoxib 10 mg 385

Cayman CAC-10091-100 Etoricoxib 100 mg 2510.2

Cayman CAC-10091-250 Etoricoxib 250 mg 5775

Cayman CAC-10091-50 Etoricoxib 50 mg 1540

Cayman CAC-10092-200 Adenosine Receptor A2A Blocking Peptide 200 µg 1647.8

Cayman CAC-10096-1 SB-242084 (hydrochloride) 1 mg 415.8

Cayman CAC-10096-10 SB-242084 (hydrochloride) 10 mg 1878.8

Cayman CAC-10096-5 SB-242084 (hydrochloride) 5 mg 1355.2

Cayman CAC-10108-1 SC-57461A 1 mg 385

Cayman CAC-10108-10 SC-57461A 10 mg 2125.2

Cayman CAC-10108-25 SC-57461A 25 mg 4820.2

Cayman CAC-10108-5 SC-57461A 5 mg 1355.2

Cayman CAC-10111-10 EA4 10 mg 2140.6

Cayman CAC-10111-100 EA4 100 mg 15738.8

Cayman CAC-10111-5 EA4 5 mg 1124.2

Cayman CAC-10111-50 EA4 50 mg 8993.6

Cayman CAC-10112-1 (±)-Enterolactone 1 mg 431.2

Cayman CAC-10112-10 (±)-Enterolactone 10 mg 3449.6

Cayman CAC-10112-5 (±)-Enterolactone 5 mg 1940.4

Cayman CAC-10112-50 (±)-Enterolactone 50 mg 15092

Cayman CAC-10113-1 AL 8810 isopropyl ester 1 mg 877.8

Cayman CAC-10113-10 AL 8810 isopropyl ester 10 mg 7022.4

Cayman CAC-10113-5 AL 8810 isopropyl ester 5 mg 3957.8

Cayman CAC-10115-10 N-Oleoyl Dopamine 10 mg 1031.8

Cayman CAC-10115-100 N-Oleoyl Dopamine 100 mg 7546

Cayman CAC-10115-5 N-Oleoyl Dopamine 5 mg 539

Cayman CAC-10115-50 N-Oleoyl Dopamine 50 mg 4312

Cayman CAC-10118-1 15(R)-Prostaglandin D2 1 mg 970.2

Cayman CAC-10118-10 15(R)-Prostaglandin D2 10 mg 8731.8

Cayman CAC-10118-5 15(R)-Prostaglandin D2 5 mg 4604.6

Cayman CAC-10120-1 CP 24,879 (hydrochloride) 1 mg 369.6

Cayman CAC-10120-10 CP 24,879 (hydrochloride) 10 mg 2956.8

Cayman CAC-10120-5 CP 24,879 (hydrochloride) 5 mg 1663.2

Cayman CAC-10120-50 CP 24,879 (hydrochloride) 50 mg 12936

Cayman CAC-10129-1 5-trans Latanoprost (free acid) 1 mg 847

Cayman CAC-10129-10 5-trans Latanoprost (free acid) 10 mg 6776

Cayman CAC-10129-5 5-trans Latanoprost (free acid) 5 mg 3819.2

Cayman CAC-10133-1 MK-886 (sodium salt) 1 mg 385

Cayman CAC-10133-10 MK-886 (sodium salt) 10 mg 1925

Cayman CAC-10133-25 MK-886 (sodium salt) 25 mg 4327.4

Cayman CAC-10133-5 MK-886 (sodium salt) 5 mg 1155

Cayman CAC-10134-1 HQL-79 1 mg 462

Cayman CAC-10134-10 HQL-79 10 mg 1848

Cayman CAC-10134-5 HQL-79 5 mg 1509.2

Cayman CAC-10134-50 HQL-79 50 mg 6930

Cayman CAC-10135-1 ICI 192605 1 mg 385

Cayman CAC-10135-10 ICI 192605 10 mg 2079

Cayman CAC-10135-25 ICI 192605 25 mg 4620

Cayman CAC-10135-5 ICI 192605 5 mg 1155

Cayman CAC-10136-1 GPR17 (C-Term) Polyclonal Antibody 1 ea 3988.6

Cayman CAC-10137-10 Icilin 10 mg 1031.8

Cayman CAC-10137-100 Icilin 100 mg 6899.2

Cayman CAC-10137-5 Icilin 5 mg 616

Cayman CAC-10137-50 Icilin 50 mg 4743.2

Cayman CAC-10138-100 (±)12-HpETE 100 µg 2201.6

Cayman CAC-10138-25 (±)12-HpETE 25 µg 1046.6

Cayman CAC-10138-50 (±)12-HpETE 50 µg 1447

Cayman CAC-10138-500 (±)12-HpETE 500 µg 7745.6

Cayman CAC-10139-1 Prostaglandin F2α-1-glyceryl ester 1 mg 924

Cayman CAC-10139-5 Prostaglandin F2α-1-glyceryl ester 5 mg 4312

Cayman CAC-10139-500 Prostaglandin F2α-1-glyceryl ester 500 µg 539

Cayman CAC-10140-1 Prostaglandin E2-1-glyceryl ester 1 mg 1708.8

Cayman CAC-10140-10 Prostaglandin E2-1-glyceryl ester 10 mg 9470.4

Cayman CAC-10140-5 Prostaglandin E2-1-glyceryl ester 5 mg 5589.6

Cayman CAC-10141-100 15-deoxy-Δ12,14-Prostaglandin J2-biotin 100 µg 3080

Cayman CAC-10141-50 15-deoxy-Δ12,14-Prostaglandin J2-biotin 50 µg 1617

Cayman CAC-10141-500 15-deoxy-Δ12,14-Prostaglandin J2-biotin 500 µg 12936

Cayman CAC-101500-1 CB1 Receptor Polyclonal Antibody 1 ea 3988.6

Cayman CAC-10155-1 BM 567 1 mg 739.2

Cayman CAC-10155-10 BM 567 10 mg 5913.6

Cayman CAC-10155-5 BM 567 5 mg 3326.4

Cayman CAC-101550-1 CB2 Receptor Polyclonal Antibody 1 ea 4296.6

Cayman CAC-10156-1 BAY u3405 1 mg 385

Cayman CAC-10156-10 BAY u3405 10 mg 2079

Cayman CAC-10156-5 BAY u3405 5 mg 1201.2

Cayman CAC-10156-50 BAY u3405 50 mg 9440.2

Cayman CAC-10157-1 APF 1 mg 3634.4

Cayman CAC-10157-5 APF 5 mg 15276.8

Cayman CAC-10157-500 APF 500 µg 1909.6

Cayman CAC-10158-1 N-Arachidonoyl-3-hydroxy-γ-Aminobutyric Acid 1 mg 169.4

Cayman CAC-10158-10 N-Arachidonoyl-3-hydroxy-γ-Aminobutyric Acid 10 mg 1355.2

Cayman CAC-10158-5 N-Arachidonoyl-3-hydroxy-γ-Aminobutyric Acid 5 mg 770

Cayman CAC-10158-50 N-Arachidonoyl-3-hydroxy-γ-Aminobutyric Acid 50 mg 5929

Cayman CAC-10159-1 HPF 1 mg 3927

Cayman CAC-10159-5 HPF 5 mg 16508.8

Cayman CAC-10159-500 HPF 500 µg 2079

Cayman CAC-101600-1 Fatty Acid Amide Hydrolase Polyclonal Antibody 1 ea 3988.6

Cayman CAC-10162-1 Treprostinil 1 mg 1216.6

Cayman CAC-10162-10 Treprostinil 10 mg 9732.8

Cayman CAC-10162-5 Treprostinil 5 mg 5482.4

Cayman CAC-101640-1 DP1 Receptor Polyclonal Antibody 1 ea 3988.6

Cayman CAC-10165-1 D-erythro-MAPP 1 mg 200.2

Cayman CAC-10165-10 D-erythro-MAPP 10 mg 1509.2

Cayman CAC-10165-5 D-erythro-MAPP 5 mg 862.4

Cayman CAC-10165-500 D-erythro-MAPP 500 µg 107.8

Cayman CAC-10168-1 Arachidonoyl p-Nitroaniline 1 mg 169.4

Cayman CAC-10168-10 Arachidonoyl p-Nitroaniline 10 mg 1355.2

Cayman CAC-10168-5 Arachidonoyl p-Nitroaniline 5 mg 770

Cayman CAC-10168-50 Arachidonoyl p-Nitroaniline 50 mg 5929

Cayman CAC-10169-100 15(S)-HETE Ethanolamide 100 µg 6930

Cayman CAC-10169-25 15(S)-HETE Ethanolamide 25 µg 1925

Cayman CAC-10169-50 15(S)-HETE Ethanolamide 50 µg 3665.2

Cayman CAC-10170-1 BEC 1 mg 446.6

Cayman CAC-10170-10 BEC 10 mg 3572.8

Cayman CAC-10170-25 BEC 25 mg 7823.2

Cayman CAC-10170-5 BEC 5 mg 2017.4

Cayman CAC-101700-500 PPARγ Polyclonal Antibody 500 µl 3988.6

Cayman CAC-10171-1 OMDM-1 1 mg 154

Cayman CAC-10171-10 OMDM-1 10 mg 1232

Cayman CAC-10171-5 OMDM-1 5 mg 693

Cayman CAC-10171-50 OMDM-1 50 mg 5390

Cayman CAC-101710-1 PPARα Polyclonal Antibody 1 ea 3988.6

Cayman CAC-10172-100 Lyso-PC 100 mg 2109.8

Cayman CAC-10172-25 Lyso-PC 25 mg 585.2

Cayman CAC-10172-50 Lyso-PC 50 mg 1108.8

Cayman CAC-10172-500 Lyso-PC 500 mg 9363.2

Cayman CAC-101720-1 PPARδ Polyclonal Antibody 1 ea 3988.6

Cayman CAC-10173-100 (±)14(15)-EpETE 100 µg 2109.8

Cayman CAC-10173-25 (±)14(15)-EpETE 25 µg 585.2

Cayman CAC-10173-50 (±)14(15)-EpETE 50 µg 1108.8

Cayman CAC-10173-500 (±)14(15)-EpETE 500 µg 9363.2

Cayman CAC-101730-500 MCAD Polyclonal Antibody 500 µl 3988.6

Cayman CAC-10174-100 (±)16(17)-EpDPA 100 µg 1832.6

Cayman CAC-10174-25 (±)16(17)-EpDPA 25 µg 508.2

Cayman CAC-10174-50 (±)16(17)-EpDPA 50 µg 970.2

Cayman CAC-10174-500 (±)16(17)-EpDPA 500 µg 8131.2

Cayman CAC-101740-1 EP1 Receptor Polyclonal Antibody 1 ea 3988.6

Cayman CAC-10175-100 (±)19(20)-EpDPA 100 µg 1832.6

Cayman CAC-10175-25 (±)19(20)-EpDPA 25 µg 508.2

Cayman CAC-10175-50 (±)19(20)-EpDPA 50 µg 970.2

Cayman CAC-10175-500 (±)19(20)-EpDPA 500 µg 8131.2

Cayman CAC-101750-500 EP2 Receptor Polyclonal Antibody 500 µl 3988.6

Cayman CAC-101760-1 EP3 Receptor Polyclonal Antibody 1 ea 3988.6

Cayman CAC-101770-1 EP4 Receptor (N-Term) Polyclonal Antiserum 1 ea 3988.6

Cayman CAC-101775-1 EP4 Receptor (C-Term) Polyclonal Antibody 1 ea 3988.6

Cayman CAC-10178-10 (+)-D-threo-PDMP (hydrochloride) 10 mg 5667.2

Cayman CAC-101780-200 EP4 Receptor (N-Term) Blocking Peptide 200 µg 1647.8

Cayman CAC-10179-1 OMDM-2 1 mg 215.6

Cayman CAC-10179-10 OMDM-2 10 mg 1724.8

Cayman CAC-10179-5 OMDM-2 5 mg 970.2

Cayman CAC-10179-50 OMDM-2 50 mg 7546

Cayman CAC-10180-1 Arachidonoyl Ethanolamide Phosphate 1 mg 1047.2

Cayman CAC-10180-250 Arachidonoyl Ethanolamide Phosphate 250 µg 292.6

Cayman CAC-10180-5 Arachidonoyl Ethanolamide Phosphate 5 mg 4681.6

Cayman CAC-10180-500 Arachidonoyl Ethanolamide Phosphate 500 µg 554.4

Cayman CAC-101802-1 FP Receptor Polyclonal Antibody 1 ea 3988.6

Cayman CAC-10185-1 4-oxo-2-Nonenal 1 mg 1924.4

Cayman CAC-10185-10 4-oxo-2-Nonenal 10 mg 10302

Cayman CAC-10185-5 4-oxo-2-Nonenal 5 mg 6144

Cayman CAC-10185-500 4-oxo-2-Nonenal 500 µg 1293

Cayman CAC-10186-1 COX Inhibitor Pack 1 ea 7823.2

Cayman CAC-10188-100 trans-trismethoxy Resveratrol 100 mg 800.8

Cayman CAC-10188-250 trans-trismethoxy Resveratrol 250 mg 1678.6

Cayman CAC-10188-50 trans-trismethoxy Resveratrol 50 mg 446.6

Cayman CAC-10188-500 trans-trismethoxy Resveratrol 500 mg 3126.2

Cayman CAC-101882-1 TP Receptor (mouse) Polyclonal Antibody 1 ea 3988.6

Cayman CAC-10189540-1 Nitrotyrosine Polyclonal Antibody 1 ea 3988.6

Cayman CAC-10190-100 2,4-Dichlorophenoxy Acetic Acid 100 g 323.4

Cayman CAC-10190-250 2,4-Dichlorophenoxy Acetic Acid 250 g 770

Cayman CAC-10190-50 2,4-Dichlorophenoxy Acetic Acid 50 g 169.4

Cayman CAC-10192-1 Prostaglandin D2 serinol amide 1 mg 847

Cayman CAC-10192-10 Prostaglandin D2 serinol amide 10 mg 7623

Cayman CAC-10192-5 Prostaglandin D2 serinol amide 5 mg 4019.4

Cayman CAC-10193-1 Prostaglandin E2 serinol amide 1 mg 1354.6

Cayman CAC-10193-10 Prostaglandin E2 serinol amide 10 mg 6205.6

Cayman CAC-10193-5 Prostaglandin E2 serinol amide 5 mg 3803.2

Cayman CAC-10193-500 Prostaglandin E2 serinol amide 500 µg 1000.4

Cayman CAC-10194-1 Prostaglandin F2α serinol amide 1 mg 877.8

Cayman CAC-10194-10 Prostaglandin F2α serinol amide 10 mg 7022.4

Cayman CAC-10194-5 Prostaglandin F2α serinol amide 5 mg 3957.8

Cayman CAC-10195-1 13-epi-12-oxo Phytodienoic Acid 1 mg 6513.6

Cayman CAC-10195-100 13-epi-12-oxo Phytodienoic Acid 100 µg 1339.2

Cayman CAC-10195-500 13-epi-12-oxo Phytodienoic Acid 500 µg 3926.4

Cayman CAC-10196-500 Rabbit Anti-Mouse IgA Polyclonal FITC 500 µl 1262.8

Cayman CAC-10197-500 Glutathione S-Transferase Polyclonal FITC Antibody 500 µl 4450.6

Cayman CAC-10203-1 AM2201 N-(4-hydroxypentyl) metabolite 1 mg 6006

Cayman CAC-10203-100 AM2201 N-(4-hydroxypentyl) metabolite 100 µg 1001

Cayman CAC-10203-500 AM2201 N-(4-hydroxypentyl) metabolite 500 µg 3757.6

Cayman CAC-10208-1 CD34 Monoclonal FITC Antibody (Clone ICO-115) 1 ea 4450.6

Cayman CAC-10209-500 Prostaglandin E Synthase (cytosolic, FL) Polyclonal Antibody 500 µl 3988.6

Cayman CAC-10210-1 Prostaglandin A2 1 mg 385

Cayman CAC-10210-10 Prostaglandin A2 10 mg 2695

Cayman CAC-10210-5 Prostaglandin A2 5 mg 1632.4

Cayman CAC-10212-500 Monoacylglycerol Lipase (FL) Polyclonal Antibody 500 µl 3988.6

Cayman CAC-10214-1 Nrf2 (C-Term) Polyclonal Antibody 1 ea 3988.6

Cayman CAC-10215-1 IDFP 1 mg 1324.4

Cayman CAC-10215-10 IDFP 10 mg 9702

Cayman CAC-10215-5 IDFP 5 mg 5544

Cayman CAC-10215-500 IDFP 500 µg 693

Cayman CAC-10217-1 24(R)-hydroxy Cholesterol 1 mg 600.6

Cayman CAC-10217-10 24(R)-hydroxy Cholesterol 10 mg 3003

Cayman CAC-10217-5 24(R)-hydroxy Cholesterol 5 mg 2109.8

Cayman CAC-10218-1 PCSK9 Monoclonal Antibody (Clone 15A6) 1 ea 3988.6

Cayman CAC-10221-100 Phosphothreonine (Ascites) Monoclonal Antibody (Clone 18F6) 100 µl 5207.4

Cayman CAC-10222-100 Phosphotyrosine (Ascites) Monoclonal Antibody (Clone 13F9) 100 µL 5207.4

Cayman CAC-10224-1 GPR55 Polyclonal Antibody 1 ea 3988.6

Cayman CAC-10225-200 GPR55 Blocking Peptide 200 µg 1647.8

Cayman CAC-10228-1 TAF 10 Peptide 1 ea 1570.8

Cayman CAC-10229-1 Amyloid-β (1-8, A2V) Peptide 1 ea 939.4

Cayman CAC-10231-1 CD3 Monoclonal FITC Antibody (Clone RIV9) 1 ea 4450.6

Cayman CAC-10232-1 CD5 Monoclonal FITC Antibody (Clone CRIS1) 1 ea 3988.6

Cayman CAC-10233-1 FABP3 Monoclonal Antibody (Clone CC68) 1 ea 3988.6

Cayman CAC-10235-1 8-iso Prostaglandin A2 1 mg 1832.6

Cayman CAC-10235-500 8-iso Prostaglandin A2 500 µg 1016.4

Cayman CAC-10239-1 IP6K2 Monoclonal Antibody (Clone 4F10) 1 ea 3988.6

Cayman CAC-10240-1 PCSK9 Polyclonal Antibody 1 ea 4296.6

Cayman CAC-10241-1 β-Amyloid (1-8) Peptide 1 ea 939.4

Cayman CAC-10242-200 11β-Hydroxysteroid Dehydrogenase (Type 2) Blocking Peptide 200 µg 1647.8

Cayman CAC-10247-1 Prostaglandin I Synthase Monoclonal Antibody (Clone 3C8) 1 ea 3988.6

Cayman CAC-10250-500 Programmed Cell Death Protein 4 (C-Term) Polyclonal Antibody 500 µl 3988.6

Cayman CAC-10253-10 Doxifluridine 10 mg 385

Cayman CAC-10253-100 Doxifluridine 100 mg 1509.2

Cayman CAC-10253-25 Doxifluridine 25 mg 723.8

Cayman CAC-10253-50 Doxifluridine 50 mg 862.4

Cayman CAC-10260-1 13,14-dihydro-15-keto Prostaglandin A2 1 mg 1047.2

Cayman CAC-10260-10 13,14-dihydro-15-keto Prostaglandin A2 10 mg 8377.6

Cayman CAC-10260-5 13,14-dihydro-15-keto Prostaglandin A2 5 mg 4712.4

Cayman CAC-10261-1 Histone H2A (Xenopus recombinant) 1 mg 7145

Cayman CAC-10262-1 Histone H2B (Xenopus recombinant) 1 mg 5990

Cayman CAC-10263-1 Histone H3 (human recombinant) 1 mg 5990

Cayman CAC-10264-1 Histone H4 (human recombinant) 1 mg 5990

Cayman CAC-10265-1 15-deoxy-Δ12,14-Prostaglandin A2 1 mg 1724.8

Cayman CAC-10265-5 15-deoxy-Δ12,14-Prostaglandin A2 5 mg 7268.8

Cayman CAC-10265-500 15-deoxy-Δ12,14-Prostaglandin A2 500 µg 908.6

Cayman CAC-10266-10 JWH 007 10 mg 1632.4

Cayman CAC-10266-25 JWH 007 25 mg 3880.8

Cayman CAC-10266-5 JWH 007 5 mg 862.4

Cayman CAC-10270-1 15(R)-15-methyl Prostaglandin A2 1 mg 662.2

Cayman CAC-10270-10 15(R)-15-methyl Prostaglandin A2 10 mg 5297.6

Cayman CAC-10270-5 15(R)-15-methyl Prostaglandin A2 5 mg 2987.6

Cayman CAC-10271-10 EUK 118 10 mg 831.6

Cayman CAC-10271-5 EUK 118 5 mg 462

Cayman CAC-10271-50 EUK 118 50 mg 3927

Cayman CAC-10272-1 Prostratin 1 mg 1355.2

Cayman CAC-10272-100 Prostratin 100 µg 169.4

Cayman CAC-10272-250 Prostratin 250 µg 400.4

Cayman CAC-10272-500 Prostratin 500 µg 770

Cayman CAC-10273-200 FABP3 Blocking Peptide 200 µg 1647.8

Cayman CAC-10277-1 ATB-337 1 mg 431.2

Cayman CAC-10277-10 ATB-337 10 mg 3449.6

Cayman CAC-10277-5 ATB-337 5 mg 1940.4

Cayman CAC-10277-50 ATB-337 50 mg 15092

Cayman CAC-10279-100 PAF Acetylhydrolase (human recombinant) 100 µg 6421.2

Cayman CAC-10280-1 16,16-dimethyl Prostaglandin A2 1 mg 1139.6

Cayman CAC-10280-10 16,16-dimethyl Prostaglandin A2 10 mg 9116.8

Cayman CAC-10280-5 16,16-dimethyl Prostaglandin A2 5 mg 5128.2

Cayman CAC-10285-1 16-phenoxy tetranor Prostaglandin A2 1 mg 739.2

Cayman CAC-10285-10 16-phenoxy tetranor Prostaglandin A2 10 mg 5913.6

Cayman CAC-10285-5 16-phenoxy tetranor Prostaglandin A2 5 mg 3326.4

Cayman CAC-10288-1 17-phenyl trinor Prostaglandin A2 1 mg 739.2

Cayman CAC-10288-10 17-phenyl trinor Prostaglandin A2 10 mg 5913.6

Cayman CAC-10288-5 17-phenyl trinor Prostaglandin A2 5 mg 3326.4

Cayman CAC-10290-1 17-phenyl trinor-13,14-dihydro Prostaglandin A2 1 mg 908.6

Cayman CAC-10290-10 17-phenyl trinor-13,14-dihydro Prostaglandin A2 10 mg 7268.8

Cayman CAC-10290-5 17-phenyl trinor-13,14-dihydro Prostaglandin A2 5 mg 4096.4

Cayman CAC-10295-100 19(R)-hydroxy Prostaglandin A2 100 µg 1524.6

Cayman CAC-10295-50 19(R)-hydroxy Prostaglandin A2 50 µg 800.8

Cayman CAC-10295-500 19(R)-hydroxy Prostaglandin A2 500 µg 6406.4

Cayman CAC-10303-200 NAPE-PLD Blocking Peptide (aa 159-172) 200 µg 1647.8

Cayman CAC-10304-200 NAPE-PLD Blocking Peptide (aa 6-20) 200 µg 1647.8

Cayman CAC-10305-1 NAPE-PLD (Internal) Polyclonal Antibody 1 ea 3988.6

Cayman CAC-10306-500 NAPE-PLD (N-Term) Polyclonal Antibody 500 µl 3988.6

Cayman CAC-10310-100 Prostaglandin A3 100 µg 3696

Cayman CAC-10310-25 Prostaglandin A3 25 µg 1216.6

Cayman CAC-10310-50 Prostaglandin A3 50 µg 2002

Cayman CAC-10311-10 (R)-(-)-Mellein 10 mg 1170.4

Cayman CAC-10311-100 (R)-(-)-Mellein 100 mg 8624

Cayman CAC-10311-5 (R)-(-)-Mellein 5 mg 616

Cayman CAC-10311-50 (R)-(-)-Mellein 50 mg 4928

Cayman CAC-10312-100 8,12-iso-iPF2α-VI-1,5-lactone 100 µg 5805.2

Cayman CAC-10312-25 8,12-iso-iPF2α-VI-1,5-lactone 25 µg 2047.6

Cayman CAC-10312-50 8,12-iso-iPF2α-VI-1,5-lactone 50 µg 3356.6

Cayman CAC-10315-100 SIRT6 (human recombinant) 100 µg 6067

Cayman CAC-10316-100 SIRT7 (human recombinant) 100 µg 6067

Cayman CAC-10317-100 SIRT4 (human recombinant) 100 µg 5528

Cayman CAC-10318-100 SIRT5 (human recombinant) 100 µg 6067

Cayman CAC-10319-100 SET8 (human recombinant) 100 µg 5682

Cayman CAC-10320-500 SET7/9 (human recombinant) 500 µg 8223

Cayman CAC-10322-1 TIM4 Monoclonal Antibody 1 ea 3988.6

Cayman CAC-10325-1 Chemokine-Like Receptor 1 Polyclonal Antibody 1 ea 3988.6

Cayman CAC-10326-200 Chemokine-Like Receptor 1 Blocking Peptide 200 µg 1647.8

Cayman CAC-10329-100 Cystathionine γ-Lyase (human recombinant) 100 µg 6067

Cayman CAC-10335-100 JMJD2D (human recombinant) 100 µg 5605

Cayman CAC-10336-100 JMJD2A (human recombinant) 100 µg 5682

Cayman CAC-10337-500 AdPLA2 Polyclonal Antibody 500 µl 4296.6

Cayman CAC-10338-200 AdPLA2 Blocking Peptide 200 µg 1647.8

Cayman CAC-10339-1 CD25 Monoclonal PE Antibody (Clone 143-13) 1 ea 4450.6

Cayman CAC-10341-25 12-Lipoxygenase (platelet-type, mouse recombinant) 25 µg 5220

Cayman CAC-10343-1 IgG1 Isotype Control FITC Monoclonal Antibody (Clone MOPC-21) 1 ea 1925

Cayman CAC-10345-200 GPR17 (C-Term) Blocking Peptide 200 µg 1647.8

Cayman CAC-10348-25 Sphingosine Kinase 1 (human recombinant) 25 µg 5451

Cayman CAC-10349-1 Cytokeratin Monoclonal FITC Antibody (Clone C-11) 1 ea 4450.6

Cayman CAC-10350-100 PRMT1 (human recombinant) 100 µg 4296

Cayman CAC-10352-100 Formaldehyde Dehydrogenase (P. putida recombinant) 100 µg 6067

Cayman CAC-10353-50 G9a (human recombinant) 50 µg 5605

Cayman CAC-10380-1 Histone H4 Peptide Substrate (15-24) 1 mg 939.4

Cayman CAC-10380-5 Histone H4 Peptide Substrate (15-24) 5 mg 3757.6

Cayman CAC-10381-1 Adropin Polyclonal Antibody 1 ea 3988.6

Cayman CAC-10382-500 JMJD2A Polyclonal Antibody 500 µl 3988.6

Cayman CAC-10383-1 JMJD2D Polyclonal Antibody 1 ea 3988.6

Cayman CAC-10384-1 Prostaglandin E2 isopropyl ester 1 mg 693

Cayman CAC-10384-10 Prostaglandin E2 isopropyl ester 10 mg 5544

Cayman CAC-10384-5 Prostaglandin E2 isopropyl ester 5 mg 3126.2

Cayman CAC-10385-1 1'-hydroxy Midazolam 1 mg 1524.6

Cayman CAC-10385-5 1'-hydroxy Midazolam 5 mg 2156

Cayman CAC-10387-1 Naringenin-4'-O-β-D-Glucuronide 1 mg 2752.2

Cayman CAC-10387-500 Naringenin-4'-O-β-D-Glucuronide 500 µg 1960.2

Cayman CAC-10388-1 Naringenin-7-O-β-D-Glucuronide 1 mg 1960.2

Cayman CAC-10388-10 Naringenin-7-O-β-D-Glucuronide 10 mg 17641.8

Cayman CAC-10388-5 Naringenin-7-O-β-D-Glucuronide 5 mg 9306

Cayman CAC-10394-1 4'-methoxy-α-Pyrrolidinopropiophenone (hydrochloride) 1 mg 754.6

Cayman CAC-10394-5 4'-methoxy-α-Pyrrolidinopropiophenone (hydrochloride) 5 mg 1894.2

Cayman CAC-10397-1 3-amino Benzamide 1 g 585.2

Cayman CAC-10397-5 3-amino Benzamide 5 g 2772

Cayman CAC-10397-500 3-amino Benzamide 500 mg 308

Cayman CAC-10398-1 TG003 1 mg 277.2

Cayman CAC-10398-10 TG003 10 mg 2217.6

Cayman CAC-10398-25 TG003 25 mg 4851

Cayman CAC-10398-5 TG003 5 mg 1247.4

Cayman CAC-10437-10 3,4-Methylenedioxy-α-Pyrrolidinobutiophenone (hydrochloride) 10 mg 1432.2

Cayman CAC-10437-5 3,4-Methylenedioxy-α-Pyrrolidinobutiophenone (hydrochloride) 5 mg 754.6

Cayman CAC-10437-50 3,4-Methylenedioxy-α-Pyrrolidinobutiophenone (hydrochloride) 50 mg 4235

Cayman CAC-10439-10 3,4-Methylenedioxy-α-Pyrrolidinopropiophenone (hydrochloride) 10 mg 1801.8

Cayman CAC-10439-5 3,4-Methylenedioxy-α-Pyrrolidinopropiophenone (hydrochloride) 5 mg 1001

Cayman CAC-10439-50 3,4-Methylenedioxy-α-Pyrrolidinopropiophenone (hydrochloride) 50 mg 6760.6

Cayman CAC-10443-1 SB939 1 mg 539

Cayman CAC-10443-10 SB939 10 mg 3234

Cayman CAC-10443-25 SB939 25 mg 7407.4

Cayman CAC-10443-5 SB939 5 mg 1755.6

Cayman CAC-10444-10 PCI 34051 10 mg 1663.2

Cayman CAC-10444-100 PCI 34051 100 mg 12289.2

Cayman CAC-10444-5 PCI 34051 5 mg 877.8

Cayman CAC-10444-50 PCI 34051 50 mg 7022.4

Cayman CAC-10445-10 α-Pyrrolidinopropiophenone (hydrochloride) 10 mg 1801.8

Cayman CAC-10445-5 α-Pyrrolidinopropiophenone (hydrochloride) 5 mg 1001

Cayman CAC-10445-50 α-Pyrrolidinopropiophenone (hydrochloride) 50 mg 6760.6

Cayman CAC-10448-10 4'-methyl-α-Pyrrolidinohexanophenone (hydrochloride) 10 mg 1801.8

Cayman CAC-10448-5 4'-methyl-α-Pyrrolidinohexanophenone (hydrochloride) 5 mg 1001

Cayman CAC-10448-50 4'-methyl-α-Pyrrolidinohexanophenone (hydrochloride) 50 mg 6760.6

Cayman CAC-10449-10 4-methoxy-α-Pyrrolidinopropiophenone (tosylate) 10 mg 1801.8

Cayman CAC-10449-5 4-methoxy-α-Pyrrolidinopropiophenone (tosylate) 5 mg 1001

Cayman CAC-10449-50 4-methoxy-α-Pyrrolidinopropiophenone (tosylate) 50 mg 6760.6

Cayman CAC-10458-1 Dihomo-γ-Linolenic Acid-d6 1 mg 1925

Cayman CAC-10458-100 Dihomo-γ-Linolenic Acid-d6 100 µg 385

Cayman CAC-10458-5 Dihomo-γ-Linolenic Acid-d6 5 mg 3280.2

Cayman CAC-10458-500 Dihomo-γ-Linolenic Acid-d6 500 µg 1062.6

Cayman CAC-10459-1 PKC 412 1 mg 847

Cayman CAC-10459-10 PKC 412 10 mg 6776

Cayman CAC-10459-25 PKC 412 25 mg 14784

Cayman CAC-10459-5 PKC 412 5 mg 3603.6

Cayman CAC-10460-1 Doramapimod 1 mg 261.8

Cayman CAC-10460-10 Doramapimod 10 mg 2094.4

Cayman CAC-10460-25 Doramapimod 25 mg 4589.2

Cayman CAC-10460-5 Doramapimod 5 mg 1185.8

Cayman CAC-10461-100 Paclitaxel 100 mg 2695

Cayman CAC-10461-25 Paclitaxel 25 mg 862.4

Cayman CAC-10461-5 Paclitaxel 5 mg 385

Cayman CAC-10461-50 Paclitaxel 50 mg 1540

Cayman CAC-10462-100 (±)11(12)-EpETE 100 µg 2109.8

Cayman CAC-10462-25 (±)11(12)-EpETE 25 µg 585.2

Cayman CAC-10462-50 (±)11(12)-EpETE 50 µg 1108.8

Cayman CAC-10462-500 (±)11(12)-EpETE 500 µg 9363.2

Cayman CAC-10464-100 (±)13(14)-EpDPA 100 µg 1832.6

Cayman CAC-10464-25 (±)13(14)-EpDPA 25 µg 508.2

Cayman CAC-10464-50 (±)13(14)-EpDPA 50 µg 970.2

Cayman CAC-10464-500 (±)13(14)-EpDPA 500 µg 8131.2

Cayman CAC-10465-100 (±)7(8)-EpDPA 100 µg 1832.6

Cayman CAC-10465-25 (±)7(8)-EpDPA 25 µg 508.2

Cayman CAC-10465-50 (±)7(8)-EpDPA 50 µg 970.2

Cayman CAC-10465-500 (±)7(8)-EpDPA 500 µg 8131.2

Cayman CAC-10466-100 11,12-DiHETE 100 µg 4604.6

Cayman CAC-10466-25 11,12-DiHETE 25 µg 1278.2

Cayman CAC-10466-50 11,12-DiHETE 50 µg 2433.2

Cayman CAC-10467-100 (±)5(6)-DiHETE 100 µg 4219.6

Cayman CAC-10467-25 (±)5(6)-DiHETE 25 µg 1170.4

Cayman CAC-10467-50 (±)5(6)-DiHETE 50 µg 2217.6

Cayman CAC-10469-100 7(8)-DiHDPA 100 µg 2017.4

Cayman CAC-10469-50 7(8)-DiHDPA 50 µg 1062.6

Cayman CAC-10469-500 7(8)-DiHDPA 500 µg 8500.8

Cayman CAC-10470-100 (±)8(9)-EpETE 100 µg 2109.8

Cayman CAC-10470-25 (±)8(9)-EpETE 25 µg 585.2

Cayman CAC-10470-50 (±)8(9)-EpETE 50 µg 1108.8

Cayman CAC-10470-500 (±)8(9)-EpETE 500 µg 9363.2

Cayman CAC-10471-100 (±)10(11)-EpDPA 100 µg 1832.6

Cayman CAC-10471-25 (±)10(11)-EpDPA 25 µg 508.2

Cayman CAC-10471-50 (±)10(11)-EpDPA 50 µg 970.2

Cayman CAC-10471-500 (±)10(11)-EpDPA 500 µg 8131.2

Cayman CAC-10473-100 8,9-DiHETE 100 µg 4650.8

Cayman CAC-10473-25 8,9-DiHETE 25 µg 1293.6

Cayman CAC-10473-50 8,9-DiHETE 50 µg 2464

Cayman CAC-10477-1 EP2 Receptor Polyclonal PE Antibody 1 ea 4604.6

Cayman CAC-10478-1 Cytokeratin Monoclonal PE Antibody (Clone C-11) 1 ea 4450.6

Cayman CAC-10479-500 EP4 Receptor (C-Term) Polyclonal PE Antibody 500 µl 4450.6

Cayman CAC-10483-1 Erlotinib 1 g 1232

Cayman CAC-10483-250 Erlotinib 250 mg 385

Cayman CAC-10483-5 Erlotinib 5 g 5390

Cayman CAC-10483-500 Erlotinib 500 mg 693

Cayman CAC-10486-1 JWH 007-d9 1 mg 1909.6

Cayman CAC-10486-500 JWH 007-d9 500 µg 1001

Cayman CAC-10487-1 Capecitabine 1 g 1108.8

Cayman CAC-10487-5 Capecitabine 5 g 4681.6

Cayman CAC-10487-500 Capecitabine 500 mg 585.2

Cayman CAC-10488-10 Bupropion (hydrochloride) 10 mg 539

Cayman CAC-10488-5 Bupropion (hydrochloride) 5 mg 385

Cayman CAC-10488-50 Bupropion (hydrochloride) 50 mg 970.2

Cayman CAC-10489-1 Candesartan cilexetil 1 g 1755.6

Cayman CAC-10489-10 Candesartan cilexetil 10 g 12936

Cayman CAC-10489-5 Candesartan cilexetil 5 g 7392

Cayman CAC-10489-500 Candesartan cilexetil 500 mg 924

Cayman CAC-10490-1 (S)-AM1241 1 mg 770

Cayman CAC-10490-10 (S)-AM1241 10 mg 6160

Cayman CAC-10490-25 (S)-AM1241 25 mg 13475

Cayman CAC-10490-5 (S)-AM1241 5 mg 3465

Cayman CAC-10491-1 (R)-AM1241 1 mg 770

Cayman CAC-10491-10 (R)-AM1241 10 mg 6160

Cayman CAC-10491-25 (R)-AM1241 25 mg 13475

Cayman CAC-10491-5 (R)-AM1241 5 mg 3465

Cayman CAC-10492-1 LP-533401 1 mg 847

Cayman CAC-10492-10 LP-533401 10 mg 6776

Cayman CAC-10492-25 LP-533401 25 mg 14830.2

Cayman CAC-10492-5 LP-533401 5 mg 3819.2

Cayman CAC-10493-10 Atorvastatin (calcium salt) 10 mg 539

Cayman CAC-10493-25 Atorvastatin (calcium salt) 25 mg 770

Cayman CAC-10493-5 Atorvastatin (calcium salt) 5 mg 385

Cayman CAC-10493-50 Atorvastatin (calcium salt) 50 mg 1355.2

Cayman CAC-10495-100 4-iodo-SAHA 100 mg 2109.8

Cayman CAC-10495-250 4-iodo-SAHA 250 mg 4989.6

Cayman CAC-10495-50 4-iodo-SAHA 50 mg 1108.8

Cayman CAC-10495-500 4-iodo-SAHA 500 mg 8870.4

Cayman CAC-10496-10 Sulforaphane 10 mg 970.2

Cayman CAC-10496-25 Sulforaphane 25 mg 2294.6

Cayman CAC-10496-5 Sulforaphane 5 mg 508.2

Cayman CAC-10496-50 Sulforaphane 50 mg 3696

Cayman CAC-10497-100 CAY10632 100 µg 5436.2

Cayman CAC-10497-25 CAY10632 25 µg 1509.2

Cayman CAC-10497-50 CAY10632 50 µg 2864.4

Cayman CAC-10498-10 HA-130 10 mg 1524.6

Cayman CAC-10498-25 HA-130 25 mg 2125.2

Cayman CAC-10498-5 HA-130 5 mg 847

Cayman CAC-10500-100 PAD4 (human recombinant) 100 µg 5204.6

Cayman CAC-10501-100 Prostaglandin Screening Library I (96-Well) 100 µl 23454.2

Cayman CAC-10501-200 Prostaglandin Screening Library I (96-Well) 200 µl 42211.4

Cayman CAC-10501-50 Prostaglandin Screening Library I (96-Well) 50 µl 14861

Cayman CAC-10502-100 Prostaglandin Screening Library II (96-Well) 100 µl 23454.2

Cayman CAC-10502-200 Prostaglandin Screening Library II (96-Well) 200 µl 42211.4

Cayman CAC-10502-50 Prostaglandin Screening Library II (96-Well) 50 µl 14861

Cayman CAC-10503-100 Prostaglandin Screening Library III (96-Well) 100 µl 23454.2

Cayman CAC-10503-200 Prostaglandin Screening Library III (96-Well) 200 µl 42211.4

Cayman CAC-10503-50 Prostaglandin Screening Library III (96-Well) 50 µl 14861

Cayman CAC-10504-100 Fatty Acid Screening Library (96-Well) 100 µl 33772.2

Cayman CAC-10504-200 Fatty Acid Screening Library (96-Well) 200 µl 60029.2

Cayman CAC-10504-50 Fatty Acid Screening Library (96-Well) 50 µl 18757.2

Cayman CAC-10505-100 Kinase Screening Library (96-Well) 100 µl 14861

Cayman CAC-10506-100 Bio-active Lipid I Screening Library (96-Well) 100 µl 150150

Cayman CAC-10506-500 Bio-active Lipid I Screening Library (96-Well) 500 µl 454300

Cayman CAC-10507-100 Bio-active Lipid II Screening Library (96-Well) 100 µl 59983

Cayman CAC-10510-1 JWH 210-d9 1 mg 1909.6

Cayman CAC-10510-500 JWH 210-d9 500 µg 1001

Cayman CAC-10515-10 3,4-DHMA (trifluoroacetate salt) 10 mg 1031.8

Cayman CAC-10515-5 3,4-DHMA (trifluoroacetate salt) 5 mg 539

Cayman CAC-10515-50 3,4-DHMA (trifluoroacetate salt) 50 mg 4312

Cayman CAC-10518-1 3,4-Methylenedioxy Pyrovalerone metabolite 1 (hydrochloride) 1 mg 1463

Cayman CAC-10518-10 3,4-Methylenedioxy Pyrovalerone metabolite 1 (hydrochloride) 10 mg 5390

Cayman CAC-10518-5 3,4-Methylenedioxy Pyrovalerone metabolite 1 (hydrochloride) 5 mg 3465

Cayman CAC-10521-1 JWH 018 N-(5-chloropentyl) analog 1 mg 1001

Cayman CAC-10521-10 JWH 018 N-(5-chloropentyl) analog 10 mg 8008

Cayman CAC-10521-5 JWH 018 N-(5-chloropentyl) analog 5 mg 4512.2

Cayman CAC-10522-1 Thapsigargin 1 mg 858

Cayman CAC-10522-10 Thapsigargin 10 mg 6270

Cayman CAC-10522-5 Thapsigargin 5 mg 3432

Cayman CAC-10523-10 Sirtinol 10 mg 1447.6

Cayman CAC-10523-25 Sirtinol 25 mg 2756.6

Cayman CAC-10523-5 Sirtinol 5 mg 847

Cayman CAC-10523-50 Sirtinol 50 mg 4158

Cayman CAC-10524-1 Paprotrain 1 mg 412.5

Cayman CAC-10524-10 Paprotrain 10 mg 1039.5

Cayman CAC-10524-5 Paprotrain 5 mg 726

Cayman CAC-10525-10 PK 11195 10 mg 808.5

Cayman CAC-10525-50 PK 11195 50 mg 3234

Cayman CAC-10527-25 Necrostatin-5 25 mg 2607

Cayman CAC-10527-5 Necrostatin-5 5 mg 577.5

Cayman CAC-10528-25 Necrostatin-7 25 mg 4504.5

Cayman CAC-10528-5 Necrostatin-7 5 mg 1287

Cayman CAC-10529-10 Methedrone (hydrochloride) 10 mg 1432.2

Cayman CAC-10529-5 Methedrone (hydrochloride) 5 mg 754.6

Cayman CAC-10529-50 Methedrone (hydrochloride) 50 mg 6036.8

Cayman CAC-10530-1 Histone H3 Trimethyl Lys9 Peptide 1 mg 2356.2

Cayman CAC-10532-1 BayCysLT2 1 mg 662.2

Cayman CAC-10532-10 BayCysLT2 10 mg 5297.6

Cayman CAC-10532-25 BayCysLT2 25 mg 11596.2

Cayman CAC-10532-5 BayCysLT2 5 mg 2987.6

Cayman CAC-10534-1 (R)-Bromoenol lactone-d7 1 mg 3572.8

Cayman CAC-10534-100 (R)-Bromoenol lactone-d7 100 µg 446.6

Cayman CAC-10534-500 (R)-Bromoenol lactone-d7 500 µg 2017.4

Cayman CAC-10535-1 (S)-Bromoenol lactone-d7 1 mg 3572.8

Cayman CAC-10535-100 (S)-Bromoenol lactone-d7 100 µg 446.6

Cayman CAC-10535-500 (S)-Bromoenol lactone-d7 500 µg 2017.4

Cayman CAC-10538-1 Arachidonic Acid Alkyne 1 mg 11704

Cayman CAC-10538-100 Arachidonic Acid Alkyne 100 µg 1463

Cayman CAC-10538-500 Arachidonic Acid Alkyne 500 µg 6591.2

Cayman CAC-10539-100 Tetratriaconta-16(Z),19(Z),22(Z),25(Z),28(Z),31(Z)-hexaenoic Acid 100 µg 5436.2

Cayman CAC-10539-25 Tetratriaconta-16(Z),19(Z),22(Z),25(Z),28(Z),31(Z)-hexaenoic Acid 25 µg 1509.2

Cayman CAC-10539-50 Tetratriaconta-16(Z),19(Z),22(Z),25(Z),28(Z),31(Z)-hexaenoic Acid 50 µg 2864.4

Cayman CAC-10541-1 Linoleic Acid Alkyne 1 mg 6036.8

Cayman CAC-10541-100 Linoleic Acid Alkyne 100 µg 754.6

Cayman CAC-10541-5 Linoleic Acid Alkyne 5 mg 26411

Cayman CAC-10541-500 Linoleic Acid Alkyne 500 µg 3403.4

Cayman CAC-10543-1 MK-8669 1 mg 508.2

Cayman CAC-10543-10 MK-8669 10 mg 3311

Cayman CAC-10543-5 MK-8669 5 mg 2294.6

Cayman CAC-10546-100 7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid 100 µg 2002

Cayman CAC-10546-25 7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid 25 µg 554.4

Cayman CAC-10546-50 7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid 50 µg 1047.2

Cayman CAC-10547-1 4-pentynoyl-Coenzyme A (trifluoroacetate salt) 1 mg 1755.6

Cayman CAC-10547-10 4-pentynoyl-Coenzyme A (trifluoroacetate salt) 10 mg 12936

Cayman CAC-10547-5 4-pentynoyl-Coenzyme A (trifluoroacetate salt) 5 mg 7392

Cayman CAC-10547-500 4-pentynoyl-Coenzyme A (trifluoroacetate salt) 500 µg 924

Cayman CAC-10549-1 C646 1 mg 478.5

Cayman CAC-10549-10 C646 10 mg 2293.5

Cayman CAC-10549-5 C646 5 mg 1386

Cayman CAC-10550-1 4-biphenylthio Carboxamide 1 g 3449.6

Cayman CAC-10550-100 4-biphenylthio Carboxamide 100 mg 431.2

Cayman CAC-10550-250 4-biphenylthio Carboxamide 250 mg 1031.8

Cayman CAC-10550-500 4-biphenylthio Carboxamide 500 mg 1940.4

Cayman CAC-10551-1 Pyrazine-2-thio Carboxamide 1 g 1971.2

Cayman CAC-10551-100 Pyrazine-2-thio Carboxamide 100 mg 246.4

Cayman CAC-10551-250 Pyrazine-2-thio Carboxamide 250 mg 585.2

Cayman CAC-10551-500 Pyrazine-2-thio Carboxamide 500 mg 1108.8

Cayman CAC-10552-1 4-methoxythio Benzamide 1 g 462

Cayman CAC-10552-5 4-methoxythio Benzamide 5 g 1971.2

Cayman CAC-10552-500 4-methoxythio Benzamide 500 mg 246.4

Cayman CAC-10553-1 3-methoxythio Benzamide 1 g 431.2

Cayman CAC-10553-5 3-methoxythio Benzamide 5 g 1370.6

Cayman CAC-10553-500 3-methoxythio Benzamide 500 mg 231

Cayman CAC-10554-10 NG-amino-L-Arginine (hydrochloride) 10 mg 1201.2

Cayman CAC-10554-25 NG-amino-L-Arginine (hydrochloride) 25 mg 2849

Cayman CAC-10554-5 NG-amino-L-Arginine (hydrochloride) 5 mg 631.4

Cayman CAC-10554-50 NG-amino-L-Arginine (hydrochloride) 50 mg 5051.2

Cayman CAC-10556-10 7-hydroxycoumarinyl-γ-Linolenate 10 mg 816.2

Cayman CAC-10556-25 7-hydroxycoumarinyl-γ-Linolenate 25 mg 1940.4

Cayman CAC-10556-5 7-hydroxycoumarinyl-γ-Linolenate 5 mg 431.2

Cayman CAC-10556-50 7-hydroxycoumarinyl-γ-Linolenate 50 mg 3449.6

Cayman CAC-10557-1 9-Nitrooleate-d17 1 mg 8901.2

Cayman CAC-10557-100 9-Nitrooleate-d17 100 µg 1201.2

Cayman CAC-10557-50 9-Nitrooleate-d17 50 µg 754.6

Cayman CAC-10557-500 9-Nitrooleate-d17 500 µg 5051.2

Cayman CAC-10558-1 10-Nitrooleate-d17 1 mg 8901.2

Cayman CAC-10558-100 10-Nitrooleate-d17 100 µg 1201.2

Cayman CAC-10558-50 10-Nitrooleate-d17 50 µg 754.6

Cayman CAC-10558-500 10-Nitrooleate-d17 500 µg 5051.2

Cayman CAC-10559-1 Tubastatin A (trifluoroacetate salt) 1 mg 385

Cayman CAC-10559-10 Tubastatin A (trifluoroacetate salt) 10 mg 1740.2

Cayman CAC-10559-5 Tubastatin A (trifluoroacetate salt) 5 mg 1155

Cayman CAC-10562-1 CAY10631 1 mg 1755.6

Cayman CAC-10562-10 CAY10631 10 mg 12936

Cayman CAC-10562-5 CAY10631 5 mg 7392

Cayman CAC-10562-500 CAY10631 500 µg 924

Cayman CAC-10563-1 MDA 19 1 mg 385

Cayman CAC-10563-10 MDA 19 10 mg 2310

Cayman CAC-10563-5 MDA 19 5 mg 1632.4

Cayman CAC-10563-50 MDA 19 50 mg 8670.2

Cayman CAC-10565-100 NVP-BEZ235 100 mg 2002

Cayman CAC-10565-25 NVP-BEZ235 25 mg 554.4

Cayman CAC-10565-250 NVP-BEZ235 250 mg 4435.2

Cayman CAC-10565-50 NVP-BEZ235 50 mg 1047.2

Cayman CAC-10566-1 Garcinol 1 mg 184.8

Cayman CAC-10566-10 Garcinol 10 mg 1216.6

Cayman CAC-10566-25 Garcinol 25 mg 2926

Cayman CAC-10566-5 Garcinol 5 mg 754.6

Cayman CAC-10569-1 Ellagic Acid 1 g 1293.6

Cayman CAC-10569-100 Ellagic Acid 100 mg 215.6

Cayman CAC-10569-500 Ellagic Acid 500 mg 862.4

Cayman CAC-10570-100 Heneicosapentaenoic Acid-d6 100 µg 3603.6

Cayman CAC-10570-25 Heneicosapentaenoic Acid-d6 25 µg 1001

Cayman CAC-10570-50 Heneicosapentaenoic Acid-d6 50 µg 1909.6

Cayman CAC-10572-1 Scriptaid 1 mg 431.2

Cayman CAC-10572-10 Scriptaid 10 mg 1724.8

Cayman CAC-10572-5 Scriptaid 5 mg 1509.2

Cayman CAC-10574-1 Suberohydroxamic Acid 1 g 2587.2

Cayman CAC-10574-100 Suberohydroxamic Acid 100 mg 323.4

Cayman CAC-10574-250 Suberohydroxamic Acid 250 mg 770

Cayman CAC-10574-500 Suberohydroxamic Acid 500 mg 1463

Cayman CAC-10575-1 Apicidin 1 mg 708.4

Cayman CAC-10575-10 Apicidin 10 mg 5313

Cayman CAC-10575-5 Apicidin 5 mg 3018.4

Cayman CAC-10576-1 HC Toxin 1 mg 1801.8

Cayman CAC-10576-5 HC Toxin 5 mg 8008

Cayman CAC-10576-500 HC Toxin 500 µg 1001

Cayman CAC-10578-10 JWH 251 10 mg 1632.4

Cayman CAC-10578-25 JWH 251 25 mg 3880.8

Cayman CAC-10578-5 JWH 251 5 mg 862.4

Cayman CAC-10580-1 HAMI3379 1 mg 662.2

Cayman CAC-10580-10 HAMI3379 10 mg 5297.6

Cayman CAC-10580-25 HAMI3379 25 mg 11596.2

Cayman CAC-10580-5 HAMI3379 5 mg 2987.6

Cayman CAC-10581-100 Prostaglandin E2-d9 100 µg 1493.8

Cayman CAC-10581-250 Prostaglandin E2-d9 250 µg 3542

Cayman CAC-10581-50 Prostaglandin E2-d9 50 µg 785.4

Cayman CAC-10581-500 Prostaglandin E2-d9 500 µg 6283.2

Cayman CAC-10582-1 UNC0321 (trifluoroacetate salt) 1 mg 585.2

Cayman CAC-10582-10 UNC0321 (trifluoroacetate salt) 10 mg 2633.4

Cayman CAC-10582-5 UNC0321 (trifluoroacetate salt) 5 mg 1463

Cayman CAC-10582-50 UNC0321 (trifluoroacetate salt) 50 mg 10241

Cayman CAC-10584-1 (-)-Neplanocin A 1 mg 6468

Cayman CAC-10584-5 (-)-Neplanocin A 5 mg 26611.2

Cayman CAC-10584-500 (-)-Neplanocin A 500 µg 3403.4

Cayman CAC-10587-1 ABC294640 1 mg 446.6

Cayman CAC-10587-10 ABC294640 10 mg 2910.6

Cayman CAC-10587-25 ABC294640 25 mg 5821.2

Cayman CAC-10587-5 ABC294640 5 mg 1678.6

Cayman CAC-10597-10 5-chloro-2-methyl-3-Isothiazolone 10 g 1047.2

Cayman CAC-10597-100 5-chloro-2-methyl-3-Isothiazolone 100 g 4158

Cayman CAC-10597-25 5-chloro-2-methyl-3-Isothiazolone 25 g 2433.2

Cayman CAC-10597-5 5-chloro-2-methyl-3-Isothiazolone 5 g 693

Cayman CAC-10599-1 Cl-Amidine (trifluoroacetate salt) 1 mg 508.2

Cayman CAC-10599-10 Cl-Amidine (trifluoroacetate salt) 10 mg 2802.8

Cayman CAC-10599-5 Cl-Amidine (trifluoroacetate salt) 5 mg 2032.8

Cayman CAC-10600-1 GABAA Receptor δ-subunit (N-Term) Polyclonal Antibody 1 ea 6831

Cayman CAC-10601-1 GluR1 (Phospho-Ser845) Polyclonal Antibody 1 ea 6831

Cayman CAC-10602-1 GluR1 (Phospho-Ser831) Polyclonal Antibody 1 ea 6831

Cayman CAC-10603-1 DARPP-32 (Phospho-Thr34) Polyclonal Antibody 1 ea 6831

Cayman CAC-10604-1 Tyrosine Hydroxylase Polyclonal Antibody 1 ea 6831

Cayman CAC-10605-1 Synapsin I Polyclonal Antibody (neat serum) 1 ea 5841

Cayman CAC-10606-1 Synapsin I Polyclonal Antibody 1 ea 6831

Cayman CAC-10607-1 NMDA Receptor NR1 Subunit Monoclonal Antibody 1 ea 6831

Cayman CAC-10608-1 NMDA Receptor NR2A Subunit Polyclonal Antibody 1 ea 6831

Cayman CAC-10609-1 NMDA Receptor NR2B Subunit Polyclonal Antibody 1 ea 6831

Cayman CAC-10610-1 F-Amidine (trifluoroacetate salt) 1 mg 3080

Cayman CAC-10610-100 F-Amidine (trifluoroacetate salt) 100 µg 385

Cayman CAC-10610-250 F-Amidine (trifluoroacetate salt) 250 µg 908.6

Cayman CAC-10610-500 F-Amidine (trifluoroacetate salt) 500 µg 1740.2

Cayman CAC-10617-10 IU1 10 mg 877.8

Cayman CAC-10617-100 IU1 100 mg 6468

Cayman CAC-10617-5 IU1 5 mg 462

Cayman CAC-10617-50 IU1 50 mg 3696

Cayman CAC-10618-10 PLX4032 10 mg 1016.4

Cayman CAC-10618-25 PLX4032 25 mg 2248.4

Cayman CAC-10618-5 PLX4032 5 mg 600.6

Cayman CAC-10618-50 PLX4032 50 mg 3911.6

Cayman CAC-10621-10 Olaparib 10 mg 847

Cayman CAC-10621-100 Olaparib 100 mg 4804.8

Cayman CAC-10621-25 Olaparib 25 mg 1801.8

Cayman CAC-10621-5 Olaparib 5 mg 600.6

Cayman CAC-10625-1 StemRegenin 1 1 mg 646.8

Cayman CAC-10625-10 StemRegenin 1 10 mg 2263.8

Cayman CAC-10625-5 StemRegenin 1 5 mg 1463

Cayman CAC-10626-1 AS-1269574 1 mg 385

Cayman CAC-10626-10 AS-1269574 10 mg 1463

Cayman CAC-10626-25 AS-1269574 25 mg 3234

Cayman CAC-10626-5 AS-1269574 5 mg 1155

Cayman CAC-10627-1 4-hydroxy Nonenal Glutathione (trifluoroacetate salt) 1 mg 1416.2

Cayman CAC-10627-10 4-hydroxy Nonenal Glutathione (trifluoroacetate salt) 10 mg 7129.6

Cayman CAC-10627-25 4-hydroxy Nonenal Glutathione (trifluoroacetate salt) 25 mg 14891.2

Cayman CAC-10627-5 4-hydroxy Nonenal Glutathione (trifluoroacetate salt) 5 mg 4280.6

Cayman CAC-10628-50 EED (human recombinant) 50 µg 5066

Cayman CAC-10631-1 Ampkinone 1 mg 693

Cayman CAC-10631-10 Ampkinone 10 mg 4851

Cayman CAC-10631-5 Ampkinone 5 mg 2772

Cayman CAC-10633-1 JWH 073 2-hydroxyindole metabolite 1 mg 1463

Cayman CAC-10633-10 JWH 073 2-hydroxyindole metabolite 10 mg 5390

Cayman CAC-10633-5 JWH 073 2-hydroxyindole metabolite 5 mg 3465

Cayman CAC-10638-1 FLLL32 1 mg 385

Cayman CAC-10638-10 FLLL32 10 mg 1355.2

Cayman CAC-10638-25 FLLL32 25 mg 2402.4

Cayman CAC-10638-5 FLLL32 5 mg 970.2

Cayman CAC-10639-1 MDA 77 1 mg 385

Cayman CAC-10639-10 MDA 77 10 mg 2310

Cayman CAC-10639-5 MDA 77 5 mg 1632.4

Cayman CAC-10639-50 MDA 77 50 mg 8670.2

Cayman CAC-10640-1 KM 233 1 mg 770

Cayman CAC-10640-10 KM 233 10 mg 6160

Cayman CAC-10640-25 KM 233 25 mg 13475

Cayman CAC-10640-5 KM 233 5 mg 3465

Cayman CAC-10641-1 JGB1741 1 mg 785.4

Cayman CAC-10641-10 JGB1741 10 mg 6283.2

Cayman CAC-10641-25 JGB1741 25 mg 13752.2

Cayman CAC-10641-5 JGB1741 5 mg 3542

Cayman CAC-10642-1 CAY10640 1 mg 646.8

Cayman CAC-10642-10 CAY10640 10 mg 4127.2

Cayman CAC-10642-5 CAY10640 5 mg 2587.2

Cayman CAC-10643-1 JWH 182 1 mg 539

Cayman CAC-10643-10 JWH 182 10 mg 3850

Cayman CAC-10643-25 JWH 182 25 mg 7623

Cayman CAC-10643-5 JWH 182 5 mg 2156

Cayman CAC-10644-1 JWH 210 1 mg 539

Cayman CAC-10644-10 JWH 210 10 mg 2233

Cayman CAC-10644-25 JWH 210 25 mg 5005

Cayman CAC-10644-5 JWH 210 5 mg 1463

Cayman CAC-10649-100 Niclosamide 100 g 1940.4

Cayman CAC-10649-25 Niclosamide 25 g 539

Cayman CAC-10649-250 Niclosamide 250 g 4312

Cayman CAC-10649-50 Niclosamide 50 g 1031.8

Cayman CAC-10651-5 FSB 5 mg 4081

Cayman CAC-10653-1 ent-Corey PG-Lactone Diol 1 mg 9363.2

Cayman CAC-10653-100 ent-Corey PG-Lactone Diol 100 µg 1170.4

Cayman CAC-10653-500 ent-Corey PG-Lactone Diol 500 µg 5266.8

Cayman CAC-10655-1 Onalespib 1 mg 600.6

Cayman CAC-10655-10 Onalespib 10 mg 4804.8

Cayman CAC-10655-25 Onalespib 25 mg 10518.2

Cayman CAC-10655-5 Onalespib 5 mg 2710.4

Cayman CAC-10658-100 MLL1 (human recombinant) 100 µg 6144

Cayman CAC-10660-1 JWH 015-d7 1 mg 1909.6

Cayman CAC-10660-500 JWH 015-d7 500 µg 1001

Cayman CAC-10664-100 Hormone-Sensitive Lipase (human recombinant) 100 µg 6067

Cayman CAC-10670-1 Heneicosapentaenoic Acid 1 mg 754.6

Cayman CAC-10670-10 Heneicosapentaenoic Acid 10 mg 6036.8

Cayman CAC-10670-25 Heneicosapentaenoic Acid 25 mg 12073.6

Cayman CAC-10670-5 Heneicosapentaenoic Acid 5 mg 3403.4

Cayman CAC-10671-1 coumarin-SAHA 1 mg 431.2

Cayman CAC-10671-10 coumarin-SAHA 10 mg 1663.2

Cayman CAC-10671-25 coumarin-SAHA 25 mg 3126.2

Cayman CAC-10671-5 coumarin-SAHA 5 mg 1108.8

Cayman CAC-10674-10 URB937 10 mg 939.4

Cayman CAC-10674-100 URB937 100 mg 6899.2

Cayman CAC-10674-5 URB937 5 mg 492.8

Cayman CAC-10674-50 URB937 50 mg 3942.4

Cayman CAC-10675-100 SAHA-BPyne 100 µg 2402.4

Cayman CAC-10675-50 SAHA-BPyne 50 µg 1262.8

Cayman CAC-10675-500 SAHA-BPyne 500 µg 10102.4

Cayman CAC-10676-1 I-BET762 1 mg 385

Cayman CAC-10676-10 I-BET762 10 mg 2510.2

Cayman CAC-10676-25 I-BET762 25 mg 5775

Cayman CAC-10676-5 I-BET762 5 mg 1355.2

Cayman CAC-10680-1 JWH 098 1 mg 539

Cayman CAC-10680-10 JWH 098 10 mg 2233

Cayman CAC-10680-25 JWH 098 25 mg 5005

Cayman CAC-10680-5 JWH 098 5 mg 1463

Cayman CAC-10681-1 C-16 Ceramide 1 mg 154

Cayman CAC-10681-10 C-16 Ceramide 10 mg 1232

Cayman CAC-10681-25 C-16 Ceramide 25 mg 2695

Cayman CAC-10681-5 C-16 Ceramide 5 mg 693

Cayman CAC-10682-1 JWH 200-d5 (exempt preparation) 1 mg 1878.8

留言框

  • 产品:

  • 留言内容:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 详细地址:

  • 省份:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7
网站首页 公司简介 产品中心 招聘中心 技术支持 企业动态 联系我们 管理登陆
上海易汇生物科技有限公司主营:Eaivelly封板膜|Eaivelly八联管|Eaivelly针式过滤器|Eaivelly光学平盖|Eaivelly荧光定量|代理GE
GoogleSitemap ICP备案号:沪ICP备16010708号-3 技术支持:化工仪器网
张经理
  • 电话

    021-62962298

在线客服
扫一扫访问手机站扫一扫访问手机站
访问手机站